data_2l6t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l6t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 121.498 0.666 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.2 mm -86.19 130.19 50.86 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.273 1.029 . . . . 0.0 109.587 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.45 164.22 35.07 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.29 2.66 . . . . 0.0 111.991 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.99 74.66 2.89 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.775 3.65 . . . . 0.0 112.961 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -139.48 -37.36 0.5 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.058 1.743 . . . . 0.0 113.174 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -84.59 -35.0 23.05 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.95 0.9 . . . . 0.0 110.874 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -96.34 176.36 6.09 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.565 1.946 . . . . 0.0 111.411 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -134.54 18.95 3.6 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.387 1.475 . . . . 0.0 112.435 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.37 73.18 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.628 -1.096 . . . . 0.0 113.782 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -53.9 146.97 25.69 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.659 1.184 . . . . 0.0 111.661 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--N 1.348 0.527 0 C-N-CA 122.879 2.386 . . . . 0.0 112.267 -175.017 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.8 p . . . . . 0 CA--C 1.549 0.909 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.6 130.29 47.72 Favored Pre-proline 0 CA--C 1.555 1.173 0 O-C-N 120.655 -1.278 . . . . 0.0 111.288 -167.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.68 169.25 22.67 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.331 3.354 . . . . 0.0 113.51 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.91 80.66 0.27 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.581 3.52 . . . . 0.0 112.956 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -149.76 -47.11 0.13 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -80.08 -17.9 51.41 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.964 1.306 . . . . 0.0 113.222 176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.57 -179.2 7.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.808 1.643 . . . . 0.0 111.192 174.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.44 21.87 4.75 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.766 1.226 . . . . 0.0 113.056 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.13 41.31 97.08 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 120.93 -1.106 . . . . 0.0 112.601 -174.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -56.51 155.97 12.79 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.241 1.417 . . . . 0.0 111.017 175.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 CA--C 1.539 0.771 0 C-N-CA 122.032 1.821 . . . . 0.0 111.805 172.27 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 122.364 1.078 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.58 132.3 95.36 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.358 1.063 . . . . 0.0 110.503 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.2 169.62 20.22 Favored 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 124.331 3.354 . . . . 0.0 112.856 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.12 75.61 1.35 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.356 3.371 . . . . 0.0 113.865 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -137.19 -37.91 0.63 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.808 1.643 . . . . 0.0 113.285 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -94.73 -34.32 12.58 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.766 -1.209 . . . . 0.0 112.006 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mp -133.59 160.0 38.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.894 2.078 . . . . 0.0 111.115 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -118.45 65.05 0.76 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.874 1.67 . . . . 0.0 111.659 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.49 7.73 6.15 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.293 1.425 . . . . 0.0 116.113 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -67.58 156.77 88.0 Favored Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 127.069 2.148 . . . . 0.0 112.636 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.458 -0.597 0 C-N-CA 122.854 2.369 . . . . 0.0 111.344 176.117 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 122.305 1.05 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.8 mt -78.9 135.47 59.09 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.887 1.275 . . . . 0.0 109.891 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.98 166.73 26.89 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.676 2.917 . . . . 0.0 112.536 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.83 84.9 0.65 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.674 3.582 . . . . 0.0 112.401 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -149.85 -55.66 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.751 0.82 . . . . 0.0 111.78 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -71.66 -24.9 61.93 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.006 1.322 . . . . 0.0 112.687 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -112.67 151.93 29.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.616 1.966 . . . . 0.0 110.637 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -141.95 16.67 2.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.566 1.546 . . . . 0.0 113.503 -174.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.01 -26.66 3.1 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.51 1.529 . . . . 0.0 113.357 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -56.66 150.99 33.13 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.67 1.188 . . . . 0.0 112.155 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo . . . . . 0 CA--C 1.538 0.724 0 C-N-CA 123.389 2.726 . . . . 0.0 112.85 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 122.338 1.066 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.5 mm -78.06 133.35 65.23 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.641 1.176 . . . . 0.0 108.544 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.5 160.26 50.01 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.714 2.276 . . . . 0.0 111.483 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.65 90.94 0.35 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.287 3.324 . . . . 0.0 111.594 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -155.52 -48.8 0.08 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.553 1.141 . . . . 0.0 111.133 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -76.08 -28.32 57.54 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.849 1.26 . . . . 0.0 112.674 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.2 mt -122.54 165.28 16.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.898 1.679 . . . . 0.0 112.413 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -130.24 31.94 4.56 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.4 1.48 . . . . 0.0 113.219 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.81 34.22 89.34 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.949 -1.094 . . . . 0.0 113.99 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -58.03 152.98 36.79 Favored Pre-proline 0 C--O 1.242 0.669 0 C-N-CA 126.335 1.854 . . . . 0.0 112.855 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 N--CA 1.459 -0.536 0 C-N-CA 123.202 2.601 . . . . 0.0 111.12 179.619 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.475 0.788 0 CA-C-O 121.999 0.904 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 mt -95.82 133.65 25.15 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.263 1.825 . . . . 0.0 109.876 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.33 165.96 28.71 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 124.211 3.274 . . . . 0.0 112.542 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.28 65.3 5.37 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.722 3.614 . . . . 0.0 113.423 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.43 19.27 3.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.188 1.795 . . . . 0.0 113.005 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -111.88 -23.21 10.69 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.614 1.166 . . . . 0.0 113.903 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.28 118.63 6.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.593 1.157 . . . . 0.0 111.512 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -105.23 34.95 3.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.836 1.254 . . . . 0.0 112.0 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.29 15.6 64.11 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.233 0.921 . . . . 0.0 114.557 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -87.47 158.01 52.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.213 -1.169 . . . . 0.0 112.416 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 C--N 1.348 0.514 0 C-N-CA 123.596 2.864 . . . . 0.0 112.182 178.173 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.9 mt -133.07 128.16 20.43 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.611 1.164 . . . . 0.0 109.273 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.6 165.88 30.47 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.111 3.207 . . . . 0.0 113.528 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.7 79.05 0.5 Allowed 'Trans proline' 0 CA--C 1.545 1.07 1 C-N-CA 125.607 4.205 . . . . 0.0 113.491 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -145.31 -49.99 0.24 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.157 1.383 . . . . 0.0 112.066 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -81.71 -35.45 29.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.236 1.015 . . . . 0.0 112.647 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.25 141.78 52.41 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.728 0.811 . . . . 0.0 110.052 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -109.57 12.2 24.47 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.3 1.04 . . . . 0.0 113.44 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.26 11.82 68.16 Favored Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.996 -1.065 . . . . 0.0 114.7 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -74.39 153.85 87.95 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.23 1.812 . . . . 0.0 112.295 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 CA--C 1.542 0.881 0 C-N-CA 124.658 3.572 . . . . 0.0 112.368 179.369 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.22 129.79 74.14 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 120.772 -1.205 . . . . 0.0 109.977 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -72.51 167.29 27.43 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.331 3.354 . . . . 0.0 112.737 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.1 76.27 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.321 3.348 . . . . 0.0 112.339 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -143.46 -41.98 0.29 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.921 2.088 . . . . 0.0 112.536 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -73.62 -29.74 62.55 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.0 mt -66.94 167.31 11.9 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.722 2.009 . . . . 0.0 112.27 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -115.64 35.11 4.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.831 1.652 . . . . 0.0 111.262 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.25 -1.78 79.41 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.975 1.274 . . . . 0.0 115.848 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -68.35 161.25 70.9 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 118.925 1.363 . . . . 0.0 111.379 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 CA--C 1.539 0.765 0 C-N-CA 123.186 2.59 . . . . 0.0 113.077 176.463 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.675 0.75 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.8 mt -90.77 128.03 49.86 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.494 1.518 . . . . 0.0 109.127 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.51 164.59 34.74 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.189 3.259 . . . . 0.0 112.361 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.0 95.38 0.36 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.138 3.225 . . . . 0.0 112.392 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -162.7 -41.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.832 1.253 . . . . 0.0 112.854 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -84.82 -18.2 35.7 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.605 1.562 . . . . 0.0 112.844 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.2 mt -125.93 -179.94 4.92 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.973 2.509 . . . . 0.0 110.527 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -136.45 53.13 1.93 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.786 1.279 . . . . 0.0 112.233 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.62 43.84 93.73 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.23 0.919 . . . . 0.0 112.846 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 153.42 57.7 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 118.008 0.904 . . . . 0.0 112.452 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 C--N 1.35 0.651 0 C-N-CA 123.064 2.509 . . . . 0.0 110.96 -178.49 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 120.945 0.402 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mt -74.92 129.13 83.9 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -64.63 167.33 15.51 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.694 2.93 . . . . 0.0 111.825 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.07 64.25 2.58 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 123.821 3.014 . . . . 0.0 112.628 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.07 -51.69 1.03 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.074 1.349 . . . . 0.0 111.598 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -57.1 -24.43 53.99 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -104.84 106.4 16.88 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.788 2.035 . . . . 0.0 108.895 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -89.37 8.88 28.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.753 1.221 . . . . 0.0 112.614 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.67 30.02 75.53 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.912 -1.117 . . . . 0.0 113.238 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -118.05 154.71 51.62 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 126.288 1.835 . . . . 0.0 110.315 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.348 0.547 0 C-N-CA 122.914 2.409 . . . . 0.0 111.116 177.201 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.544 0.721 0 CA-C-O 122.328 1.061 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.1 mt -112.88 131.54 22.72 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.639 1.576 . . . . 0.0 108.908 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.23 164.35 35.32 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.191 2.594 . . . . 0.0 112.606 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.18 73.64 1.55 Allowed 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.472 3.448 . . . . 0.0 113.208 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -136.78 -52.49 0.7 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.369 1.868 . . . . 0.0 112.316 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -58.53 -28.74 65.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.5 mt -154.64 164.75 38.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.087 2.555 . . . . 0.0 108.933 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.36 30.04 7.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.459 1.504 . . . . 0.0 112.797 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.45 26.07 74.71 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.598 -1.314 . . . . 0.0 113.639 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -55.44 150.52 23.57 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.839 1.255 . . . . 0.0 112.071 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.35 0.615 0 C-N-CA 122.941 2.428 . . . . 0.0 110.059 176.541 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.73 131.42 39.74 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.499 1.519 . . . . 0.0 109.244 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.23 172.25 9.1 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.018 3.145 . . . . 0.0 112.792 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.52 63.67 2.24 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 124.436 3.424 . . . . 0.0 113.533 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -128.29 14.68 6.68 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.315 1.446 . . . . 0.0 114.333 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -122.66 9.64 9.59 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.548 1.539 . . . . 0.0 112.707 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.55 171.82 7.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.477 1.911 . . . . 0.0 111.626 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -130.46 13.97 5.5 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.114 1.365 . . . . 0.0 112.662 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.79 -45.94 1.25 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.556 2.027 . . . . 0.0 112.369 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -76.65 162.32 71.02 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.821 1.648 . . . . 0.0 112.343 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 CA--C 1.542 0.884 0 C-N-CA 123.64 2.893 . . . . 0.0 112.858 173.909 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.444 0.64 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.19 130.33 74.48 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.488 1.515 . . . . 0.0 109.425 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.74 162.75 33.25 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.938 2.425 . . . . 0.0 111.625 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.52 73.62 0.87 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.015 3.143 . . . . 0.0 112.538 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -141.36 9.3 2.05 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.153 2.181 . . . . 0.0 112.835 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -103.23 -32.78 9.44 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.1 1.36 . . . . 0.0 113.977 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 pp -80.75 153.18 27.94 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.745 1.218 . . . . 0.0 110.959 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -125.75 15.35 8.08 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.504 1.121 . . . . 0.0 113.304 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.56 -4.5 9.36 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.713 1.149 . . . . 0.0 114.652 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -123.99 159.7 55.3 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 127.377 2.271 . . . . 0.0 110.826 -174.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 CA--C 1.541 0.846 0 C-N-CA 122.505 2.137 . . . . 0.0 112.915 171.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.7 mm 56.25 67.05 3.01 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 125.382 1.473 . . . . 0.0 112.133 -173.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.76 160.13 48.04 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.876 3.051 . . . . 0.0 112.577 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.45 58.51 2.45 Favored 'Trans proline' 0 CA--C 1.547 1.159 1 C-N-CA 126.973 5.116 . . . . 0.0 115.106 -169.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -139.68 24.41 2.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.491 1.916 . . . . 0.0 111.874 -165.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -120.51 140.19 51.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.87 1.668 . . . . 0.0 110.198 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.43 -71.86 0.41 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.706 1.202 . . . . 0.0 110.513 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -173.61 164.19 4.42 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.27 2.228 . . . . 0.0 109.624 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.74 132.45 3.18 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.634 1.588 . . . . 0.0 110.477 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.7 tptp 30.72 69.27 0.69 Allowed Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.777 2.031 . . . . 0.0 113.662 -174.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 C-N-CA 123.628 2.885 . . . . 0.0 111.354 -173.309 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.94 140.69 55.21 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.866 0.866 . . . . 0.0 111.4 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.52 132.32 46.09 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.883 0.873 . . . . 0.0 112.072 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.6 mt -93.1 131.79 32.27 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.183 0.993 . . . . 0.0 109.879 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -68.91 174.05 9.31 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.322 2.681 . . . . 0.0 113.785 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.8 m -111.22 75.98 0.95 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.428 1.491 . . . . 0.0 110.48 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 t -81.77 45.78 0.93 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.544 1.137 . . . . 0.0 112.368 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.2 mm -86.19 130.19 50.86 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.273 1.029 . . . . 0.0 109.587 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.45 164.22 35.07 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.29 2.66 . . . . 0.0 111.991 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.99 74.66 2.89 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.775 3.65 . . . . 0.0 112.961 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -139.48 -37.36 0.5 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.058 1.743 . . . . 0.0 113.174 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -84.59 -35.0 23.05 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.95 0.9 . . . . 0.0 110.874 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -96.34 176.36 6.09 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.565 1.946 . . . . 0.0 111.411 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -134.54 18.95 3.6 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.387 1.475 . . . . 0.0 112.435 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.37 73.18 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.628 -1.096 . . . . 0.0 113.782 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -53.9 146.97 25.69 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.659 1.184 . . . . 0.0 111.661 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.27 113.63 2.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.879 2.386 . . . . 0.0 112.267 -175.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -69.45 176.79 3.21 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.949 0.88 . . . . 0.0 112.243 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.46 122.31 18.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 O-C-N 120.702 -1.249 . . . . 0.0 110.662 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 . . . . . 0 C--O 1.304 3.937 0 C-N-CA 126.9 2.08 . . . . 0.0 110.488 177.632 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 119.742 -0.17 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -53.33 115.75 2.08 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.864 0.866 . . . . 0.0 112.509 167.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.23 142.11 22.06 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.132 1.373 . . . . 0.0 109.801 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.2 mt -75.34 134.95 73.03 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.439 1.096 . . . . 0.0 109.577 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.1 103.57 1.07 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.378 2.718 . . . . 0.0 111.493 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.6 m -137.4 119.9 15.97 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.994 1.718 . . . . 0.0 110.552 -173.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.8 p -70.4 39.84 0.05 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 128.951 2.9 . . . . 0.0 115.924 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.6 130.29 47.72 Favored Pre-proline 0 CA--C 1.555 1.173 0 O-C-N 120.655 -1.278 . . . . 0.0 111.288 -167.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.68 169.25 22.67 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.331 3.354 . . . . 0.0 113.51 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.91 80.66 0.27 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.581 3.52 . . . . 0.0 112.956 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -149.76 -47.11 0.13 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -80.08 -17.9 51.41 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.964 1.306 . . . . 0.0 113.222 176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.57 -179.2 7.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.808 1.643 . . . . 0.0 111.192 174.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.44 21.87 4.75 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.766 1.226 . . . . 0.0 113.056 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.13 41.31 97.08 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 120.93 -1.106 . . . . 0.0 112.601 -174.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -56.51 155.97 12.79 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.241 1.417 . . . . 0.0 111.017 175.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.18 156.38 55.73 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.032 1.821 . . . . 0.0 111.805 172.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -75.42 152.12 38.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.289 0.635 . . . . 0.0 111.702 168.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.2 m -76.89 161.95 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.301 1.441 . . . . 0.0 113.096 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.467 1.507 . . . . 0.0 112.498 -176.73 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -142.23 71.2 1.34 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.456 1.502 . . . . 0.0 109.019 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.17 43.22 3.04 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.727 1.211 . . . . 0.0 111.161 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mm -46.95 127.82 8.8 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.727 1.611 . . . . 0.0 110.713 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.02 87.76 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.719 2.946 . . . . 0.0 111.778 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.43 138.13 34.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.767 0.827 . . . . 0.0 111.195 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p -110.64 77.84 1.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.778 1.631 . . . . 0.0 111.297 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.58 132.3 95.36 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.358 1.063 . . . . 0.0 110.503 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.2 169.62 20.22 Favored 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 124.331 3.354 . . . . 0.0 112.856 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.12 75.61 1.35 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.356 3.371 . . . . 0.0 113.865 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -137.19 -37.91 0.63 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.808 1.643 . . . . 0.0 113.285 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -94.73 -34.32 12.58 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.766 -1.209 . . . . 0.0 112.006 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mp -133.59 160.0 38.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.894 2.078 . . . . 0.0 111.115 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -118.45 65.05 0.76 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.874 1.67 . . . . 0.0 111.659 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.49 7.73 6.15 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.293 1.425 . . . . 0.0 116.113 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -67.58 156.77 88.0 Favored Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 127.069 2.148 . . . . 0.0 112.636 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.03 138.03 42.73 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.854 2.369 . . . . 0.0 111.344 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -86.12 130.01 34.66 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.784 0.834 . . . . 0.0 110.379 172.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.8 m -84.86 161.51 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.373 1.469 . . . . 0.0 111.99 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.7 t80 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.01 0.924 . . . . 0.0 111.24 -178.688 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.5 mt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.65 0.262 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -58.82 135.27 57.45 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.423 1.489 . . . . 0.0 113.003 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.88 136.9 42.73 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.667 1.187 . . . . 0.0 111.07 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.6 mt -78.26 135.86 61.47 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.35 119.84 6.67 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.112 1.875 . . . . 0.0 110.063 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -125.86 156.53 39.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.409 1.483 . . . . 0.0 110.665 176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.9 t -118.87 31.59 6.57 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.485 1.114 . . . . 0.0 111.884 -169.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.8 mt -78.9 135.47 59.09 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.887 1.275 . . . . 0.0 109.891 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.98 166.73 26.89 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.676 2.917 . . . . 0.0 112.536 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.83 84.9 0.65 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.674 3.582 . . . . 0.0 112.401 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -149.85 -55.66 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.751 0.82 . . . . 0.0 111.78 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -71.66 -24.9 61.93 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.006 1.322 . . . . 0.0 112.687 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -112.67 151.93 29.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.616 1.966 . . . . 0.0 110.637 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -141.95 16.67 2.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.566 1.546 . . . . 0.0 113.503 -174.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.01 -26.66 3.1 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.51 1.529 . . . . 0.0 113.357 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -56.66 150.99 33.13 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.67 1.188 . . . . 0.0 112.155 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.83 174.04 11.78 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.389 2.726 . . . . 0.0 112.85 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -117.73 11.09 13.53 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.091 1.356 . . . . 0.0 112.955 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.84 83.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.823 1.649 . . . . 0.0 111.833 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.7 p90 . . . . . 0 C--O 1.254 1.335 0 C-N-CA 126.069 1.748 . . . . 0.0 112.876 -177.721 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 119.55 -0.262 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -136.24 111.79 9.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.735 2.014 . . . . 0.0 108.685 170.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.02 110.72 13.25 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.49 1.116 . . . . 0.0 110.784 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.78 128.47 81.62 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.798 0.839 . . . . 0.0 109.557 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -71.6 152.98 60.02 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.202 2.601 . . . . 0.0 112.566 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.0 m -67.98 110.15 3.78 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.745 0.818 . . . . 0.0 111.148 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -136.16 30.49 3.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.228 1.411 . . . . 0.0 112.054 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.5 mm -78.06 133.35 65.23 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.641 1.176 . . . . 0.0 108.544 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.5 160.26 50.01 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.714 2.276 . . . . 0.0 111.483 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.65 90.94 0.35 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.287 3.324 . . . . 0.0 111.594 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -155.52 -48.8 0.08 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.553 1.141 . . . . 0.0 111.133 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -76.08 -28.32 57.54 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.849 1.26 . . . . 0.0 112.674 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.2 mt -122.54 165.28 16.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.898 1.679 . . . . 0.0 112.413 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -130.24 31.94 4.56 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.4 1.48 . . . . 0.0 113.219 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.81 34.22 89.34 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.949 -1.094 . . . . 0.0 113.99 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -58.03 152.98 36.79 Favored Pre-proline 0 C--O 1.242 0.669 0 C-N-CA 126.335 1.854 . . . . 0.0 112.855 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.72 135.27 37.95 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.202 2.601 . . . . 0.0 111.12 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.73 104.57 0.69 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.968 0.907 . . . . 0.0 111.004 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.5 m -59.41 138.44 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.565 0.746 . . . . 0.0 110.053 170.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--O 1.264 1.845 0 CA-C-O 117.121 -1.419 . . . . 0.0 110.655 177.514 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -89.02 128.49 35.72 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.189 -0.945 . . . . 0.0 111.288 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.43 152.76 29.39 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.322 1.049 . . . . 0.0 111.377 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.9 mt -73.97 134.67 77.72 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.946 0.898 . . . . 0.0 109.511 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.2 171.12 14.41 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.259 2.639 . . . . 0.0 113.068 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.4 m -67.06 126.18 28.34 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.254 -0.904 . . . . 0.0 111.24 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 t -133.87 25.15 3.98 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.71 1.604 . . . . 0.0 111.624 -173.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 mt -95.82 133.65 25.15 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.263 1.825 . . . . 0.0 109.876 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.33 165.96 28.71 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 124.211 3.274 . . . . 0.0 112.542 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.28 65.3 5.37 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.722 3.614 . . . . 0.0 113.423 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.43 19.27 3.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.188 1.795 . . . . 0.0 113.005 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -111.88 -23.21 10.69 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.614 1.166 . . . . 0.0 113.903 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.28 118.63 6.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.593 1.157 . . . . 0.0 111.512 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -105.23 34.95 3.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.836 1.254 . . . . 0.0 112.0 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.29 15.6 64.11 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.233 0.921 . . . . 0.0 114.557 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -87.47 158.01 52.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.213 -1.169 . . . . 0.0 112.416 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.6 165.34 29.69 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.596 2.864 . . . . 0.0 112.182 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -67.46 162.15 23.81 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.6 m -125.37 44.46 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.165 1.386 . . . . 0.0 111.681 -173.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 124.825 1.25 . . . . 0.0 112.071 178.1 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.4 0.143 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -74.12 65.16 1.11 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.487 1.515 . . . . 0.0 113.289 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.24 91.49 0.96 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.377 1.471 . . . . 0.0 111.882 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.9 mt -92.58 137.47 24.33 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.362 1.065 . . . . 0.0 108.911 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.39 162.11 43.43 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.304 2.669 . . . . 0.0 112.34 174.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.9 t -147.01 126.34 13.09 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.387 -0.821 . . . . 0.0 112.054 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 t -146.11 135.6 23.07 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.516 0.726 . . . . 0.0 112.206 172.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.9 mt -133.07 128.16 20.43 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.611 1.164 . . . . 0.0 109.273 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.6 165.88 30.47 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.111 3.207 . . . . 0.0 113.528 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.7 79.05 0.5 Allowed 'Trans proline' 0 CA--C 1.545 1.07 1 C-N-CA 125.607 4.205 . . . . 0.0 113.491 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -145.31 -49.99 0.24 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.157 1.383 . . . . 0.0 112.066 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -81.71 -35.45 29.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.236 1.015 . . . . 0.0 112.647 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.25 141.78 52.41 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.728 0.811 . . . . 0.0 110.052 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -109.57 12.2 24.47 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.3 1.04 . . . . 0.0 113.44 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.26 11.82 68.16 Favored Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.996 -1.065 . . . . 0.0 114.7 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -74.39 153.85 87.95 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.23 1.812 . . . . 0.0 112.295 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.21 89.08 0.81 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 124.658 3.572 . . . . 0.0 112.368 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 t80 58.32 21.0 7.79 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.753 1.621 . . . . 0.0 114.437 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.73 46.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 126.716 2.006 . . . . 0.0 112.874 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.8 p90 . . . . . 0 C--O 1.247 0.928 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 173.109 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -106.17 32.89 4.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.903 1.281 . . . . 0.0 111.8 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.62 85.9 1.19 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.286 1.434 . . . . 0.0 111.787 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.3 mm -76.27 134.41 70.56 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.898 0.879 . . . . 0.0 110.299 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.26 -173.24 0.74 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.013 3.142 . . . . 0.0 113.007 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.0 m -117.84 4.24 12.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.177 1.391 . . . . 0.0 113.013 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -80.09 29.86 0.27 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.537 1.935 . . . . 0.0 113.793 177.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.22 129.79 74.14 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 120.772 -1.205 . . . . 0.0 109.977 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -72.51 167.29 27.43 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.331 3.354 . . . . 0.0 112.737 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.1 76.27 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.321 3.348 . . . . 0.0 112.339 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -143.46 -41.98 0.29 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.921 2.088 . . . . 0.0 112.536 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -73.62 -29.74 62.55 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.0 mt -66.94 167.31 11.9 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.722 2.009 . . . . 0.0 112.27 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -115.64 35.11 4.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.831 1.652 . . . . 0.0 111.262 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.25 -1.78 79.41 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.975 1.274 . . . . 0.0 115.848 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -68.35 161.25 70.9 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 118.925 1.363 . . . . 0.0 111.379 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.55 160.97 47.74 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.186 2.59 . . . . 0.0 113.077 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -79.95 90.42 5.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.908 1.283 . . . . 0.0 110.36 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.69 159.05 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.267 0.627 . . . . 0.0 112.419 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.3 t80 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 124.551 1.14 . . . . 0.0 111.746 -173.824 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.47 80.5 1.68 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.32 1.048 . . . . 0.0 111.876 -175.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.89 134.29 56.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.575 1.55 . . . . 0.0 112.989 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.5 mt -67.92 128.11 93.35 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.952 0.901 . . . . 0.0 109.866 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.29 114.53 3.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.963 2.442 . . . . 0.0 110.684 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.4 m -140.0 157.1 46.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.116 1.766 . . . . 0.0 110.019 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -84.03 59.21 5.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.63 1.172 . . . . 0.0 111.403 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.8 mt -90.77 128.03 49.86 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.494 1.518 . . . . 0.0 109.127 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.51 164.59 34.74 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.189 3.259 . . . . 0.0 112.361 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.0 95.38 0.36 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.138 3.225 . . . . 0.0 112.392 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -162.7 -41.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.832 1.253 . . . . 0.0 112.854 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -84.82 -18.2 35.7 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.605 1.562 . . . . 0.0 112.844 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.2 mt -125.93 -179.94 4.92 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.973 2.509 . . . . 0.0 110.527 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -136.45 53.13 1.93 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.786 1.279 . . . . 0.0 112.233 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.62 43.84 93.73 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.23 0.919 . . . . 0.0 112.846 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 153.42 57.7 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 118.008 0.904 . . . . 0.0 112.452 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.36 100.39 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.064 2.509 . . . . 0.0 110.96 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -78.71 128.33 33.29 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.859 -0.525 . . . . 0.0 110.539 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.85 112.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.774 0.829 . . . . 0.0 110.687 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 124.364 1.066 . . . . 0.0 112.687 -176.58 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 76.4 mt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -134.88 27.18 3.6 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.962 1.705 . . . . 0.0 112.809 -176.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.72 46.75 0.69 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.218 2.207 . . . . 0.0 113.757 -176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.7 127.3 66.93 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.472 1.109 . . . . 0.0 110.677 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.07 141.24 47.46 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.022 2.481 . . . . 0.0 111.591 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.1 p -150.36 161.46 42.44 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.095 0.958 . . . . 0.0 112.214 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.3 m -143.7 62.05 1.37 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.553 1.141 . . . . 0.0 110.132 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mt -74.92 129.13 83.9 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -64.63 167.33 15.51 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.694 2.93 . . . . 0.0 111.825 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.07 64.25 2.58 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 123.821 3.014 . . . . 0.0 112.628 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.07 -51.69 1.03 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.074 1.349 . . . . 0.0 111.598 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -57.1 -24.43 53.99 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -104.84 106.4 16.88 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.788 2.035 . . . . 0.0 108.895 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -89.37 8.88 28.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.753 1.221 . . . . 0.0 112.614 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.67 30.02 75.53 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.912 -1.117 . . . . 0.0 113.238 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -118.05 154.71 51.62 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 126.288 1.835 . . . . 0.0 110.315 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.05 132.82 33.3 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.914 2.409 . . . . 0.0 111.116 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -141.36 163.29 33.33 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.765 2.026 . . . . 0.0 109.02 -173.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.32 142.01 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 O-C-N 121.143 -0.973 . . . . 0.0 112.473 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 127.521 2.329 . . . . 0.0 113.619 -175.625 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -117.2 3.25 12.65 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.645 1.178 . . . . 0.0 113.262 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.72 113.77 6.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.214 1.406 . . . . 0.0 111.54 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.63 134.22 92.61 Favored Pre-proline 0 N--CA 1.474 0.758 0 C-N-CA 124.521 1.129 . . . . 0.0 110.247 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.27 123.32 10.44 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.617 2.211 . . . . 0.0 111.059 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.8 t -129.4 6.28 5.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.399 1.079 . . . . 0.0 112.269 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -89.99 50.21 1.84 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.182 1.793 . . . . 0.0 110.931 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.1 mt -112.88 131.54 22.72 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.639 1.576 . . . . 0.0 108.908 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.23 164.35 35.32 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.191 2.594 . . . . 0.0 112.606 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.18 73.64 1.55 Allowed 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.472 3.448 . . . . 0.0 113.208 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -136.78 -52.49 0.7 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.369 1.868 . . . . 0.0 112.316 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -58.53 -28.74 65.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.5 mt -154.64 164.75 38.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.087 2.555 . . . . 0.0 108.933 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.36 30.04 7.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.459 1.504 . . . . 0.0 112.797 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.45 26.07 74.71 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.598 -1.314 . . . . 0.0 113.639 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -55.44 150.52 23.57 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.839 1.255 . . . . 0.0 112.071 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -61.76 128.97 26.01 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.941 2.428 . . . . 0.0 110.059 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -117.53 105.63 12.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.986 0.914 . . . . 0.0 110.058 -170.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.43 40.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.436 1.494 . . . . 0.0 112.859 -165.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.5 t80 . . . . . 0 C--O 1.255 1.366 0 C-N-CA 125.562 1.545 . . . . 0.0 111.57 -174.359 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 121.251 0.548 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.05 83.62 2.28 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.416 0.686 . . . . 0.0 111.344 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.75 135.48 49.8 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.839 0.855 . . . . 0.0 110.763 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 mm -77.13 126.86 84.74 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.255 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -67.68 172.46 10.47 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.462 2.774 . . . . 0.0 111.642 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.9 m -72.63 127.41 32.47 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.653 -0.655 . . . . 0.0 111.367 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.5 p -132.35 13.19 4.6 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.978 0.911 . . . . 0.0 112.976 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.73 131.42 39.74 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.499 1.519 . . . . 0.0 109.244 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.23 172.25 9.1 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.018 3.145 . . . . 0.0 112.792 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.52 63.67 2.24 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 124.436 3.424 . . . . 0.0 113.533 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -128.29 14.68 6.68 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.315 1.446 . . . . 0.0 114.333 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -122.66 9.64 9.59 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.548 1.539 . . . . 0.0 112.707 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.55 171.82 7.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.477 1.911 . . . . 0.0 111.626 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -130.46 13.97 5.5 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.114 1.365 . . . . 0.0 112.662 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.79 -45.94 1.25 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.556 2.027 . . . . 0.0 112.369 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -76.65 162.32 71.02 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.821 1.648 . . . . 0.0 112.343 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.73 179.63 3.03 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.64 2.893 . . . . 0.0 112.858 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -123.73 164.35 19.32 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.398 1.079 . . . . 0.0 111.518 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.5 t -129.78 130.19 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.777 1.231 . . . . 0.0 110.149 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 124.829 1.252 . . . . 0.0 111.046 178.127 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -84.28 47.06 1.28 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.832 1.253 . . . . 0.0 111.794 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.55 71.66 3.19 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.272 1.429 . . . . 0.0 112.154 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.3 mt -49.21 128.46 16.27 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.009 1.324 . . . . 0.0 111.555 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.95 143.75 61.67 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.76 2.307 . . . . 0.0 111.703 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.3 p -148.68 160.84 42.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.843 1.257 . . . . 0.0 110.529 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.72 24.48 1.87 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.702 1.201 . . . . 0.0 112.508 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.19 130.33 74.48 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.488 1.515 . . . . 0.0 109.425 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.74 162.75 33.25 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.938 2.425 . . . . 0.0 111.625 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.52 73.62 0.87 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.015 3.143 . . . . 0.0 112.538 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -141.36 9.3 2.05 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.153 2.181 . . . . 0.0 112.835 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -103.23 -32.78 9.44 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.1 1.36 . . . . 0.0 113.977 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 pp -80.75 153.18 27.94 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.745 1.218 . . . . 0.0 110.959 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -125.75 15.35 8.08 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.504 1.121 . . . . 0.0 113.304 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.56 -4.5 9.36 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.713 1.149 . . . . 0.0 114.652 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -123.99 159.7 55.3 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 127.377 2.271 . . . . 0.0 110.826 -174.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.88 160.39 47.12 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.505 2.137 . . . . 0.0 112.915 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -62.84 149.3 44.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.621 1.168 . . . . 0.0 111.806 171.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.8 t -87.83 120.06 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.698 0.799 . . . . 0.0 111.156 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 C--O 1.249 1.056 0 C-N-CA 125.504 1.522 . . . . 0.0 112.624 178.118 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -77.55 58.24 1.72 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.441 1.497 . . . . 0.0 112.852 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.14 130.42 19.76 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.413 1.085 . . . . 0.0 111.54 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.0 152.56 62.18 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 126.171 1.788 . . . . 0.0 110.11 -174.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.13 -32.56 20.95 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.455 2.103 . . . . 0.0 112.32 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 30.5 p -76.92 169.08 18.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.641 1.576 . . . . 0.0 114.052 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 t -102.3 41.15 1.25 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.929 1.292 . . . . 0.0 112.888 -173.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.7 mm 56.25 67.05 3.01 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 125.382 1.473 . . . . 0.0 112.133 -173.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.76 160.13 48.04 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.876 3.051 . . . . 0.0 112.577 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.45 58.51 2.45 Favored 'Trans proline' 0 CA--C 1.547 1.159 1 C-N-CA 126.973 5.116 . . . . 0.0 115.106 -169.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -139.68 24.41 2.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.491 1.916 . . . . 0.0 111.874 -165.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -120.51 140.19 51.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.87 1.668 . . . . 0.0 110.198 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.43 -71.86 0.41 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.706 1.202 . . . . 0.0 110.513 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -173.61 164.19 4.42 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.27 2.228 . . . . 0.0 109.624 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.74 132.45 3.18 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.634 1.588 . . . . 0.0 110.477 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.7 tptp 30.72 69.27 0.69 Allowed Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.777 2.031 . . . . 0.0 113.662 -174.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.72 89.57 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.628 2.885 . . . . 0.0 111.354 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -120.17 23.9 10.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.884 1.674 . . . . 0.0 112.118 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.88 -178.49 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 128.061 2.544 . . . . 0.0 109.129 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.6 p90 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.478 1.911 . . . . 0.0 115.655 179.227 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 121.498 0.666 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.2 mm -86.19 130.19 50.86 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.273 1.029 . . . . 0.0 109.587 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.45 164.22 35.07 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.29 2.66 . . . . 0.0 111.991 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.99 74.66 2.89 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.775 3.65 . . . . 0.0 112.961 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -139.48 -37.36 0.5 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.058 1.743 . . . . 0.0 113.174 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -84.59 -35.0 23.05 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.95 0.9 . . . . 0.0 110.874 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -96.34 176.36 6.09 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.565 1.946 . . . . 0.0 111.411 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -134.54 18.95 3.6 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.387 1.475 . . . . 0.0 112.435 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.37 73.18 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.628 -1.096 . . . . 0.0 113.782 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -53.9 146.97 25.69 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.659 1.184 . . . . 0.0 111.661 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--N 1.348 0.527 0 C-N-CA 122.879 2.386 . . . . 0.0 112.267 -175.017 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.8 p . . . . . 0 CA--C 1.549 0.909 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.6 130.29 47.72 Favored Pre-proline 0 CA--C 1.555 1.173 0 O-C-N 120.655 -1.278 . . . . 0.0 111.288 -167.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.68 169.25 22.67 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.331 3.354 . . . . 0.0 113.51 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.91 80.66 0.27 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.581 3.52 . . . . 0.0 112.956 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -149.76 -47.11 0.13 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -80.08 -17.9 51.41 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.964 1.306 . . . . 0.0 113.222 176.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.57 -179.2 7.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.808 1.643 . . . . 0.0 111.192 174.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.44 21.87 4.75 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.766 1.226 . . . . 0.0 113.056 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.13 41.31 97.08 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 120.93 -1.106 . . . . 0.0 112.601 -174.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -56.51 155.97 12.79 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.241 1.417 . . . . 0.0 111.017 175.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 CA--C 1.539 0.771 0 C-N-CA 122.032 1.821 . . . . 0.0 111.805 172.27 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 122.364 1.078 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.58 132.3 95.36 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.358 1.063 . . . . 0.0 110.503 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.2 169.62 20.22 Favored 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 124.331 3.354 . . . . 0.0 112.856 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.12 75.61 1.35 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.356 3.371 . . . . 0.0 113.865 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -137.19 -37.91 0.63 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.808 1.643 . . . . 0.0 113.285 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -94.73 -34.32 12.58 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.766 -1.209 . . . . 0.0 112.006 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mp -133.59 160.0 38.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.894 2.078 . . . . 0.0 111.115 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -118.45 65.05 0.76 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.874 1.67 . . . . 0.0 111.659 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.49 7.73 6.15 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.293 1.425 . . . . 0.0 116.113 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -67.58 156.77 88.0 Favored Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 127.069 2.148 . . . . 0.0 112.636 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.458 -0.597 0 C-N-CA 122.854 2.369 . . . . 0.0 111.344 176.117 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 122.305 1.05 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.8 mt -78.9 135.47 59.09 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.887 1.275 . . . . 0.0 109.891 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.98 166.73 26.89 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.676 2.917 . . . . 0.0 112.536 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.83 84.9 0.65 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.674 3.582 . . . . 0.0 112.401 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -149.85 -55.66 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.751 0.82 . . . . 0.0 111.78 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -71.66 -24.9 61.93 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.006 1.322 . . . . 0.0 112.687 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -112.67 151.93 29.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.616 1.966 . . . . 0.0 110.637 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -141.95 16.67 2.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.566 1.546 . . . . 0.0 113.503 -174.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.01 -26.66 3.1 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.51 1.529 . . . . 0.0 113.357 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -56.66 150.99 33.13 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.67 1.188 . . . . 0.0 112.155 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo . . . . . 0 CA--C 1.538 0.724 0 C-N-CA 123.389 2.726 . . . . 0.0 112.85 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 122.338 1.066 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.5 mm -78.06 133.35 65.23 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.641 1.176 . . . . 0.0 108.544 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.5 160.26 50.01 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.714 2.276 . . . . 0.0 111.483 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.65 90.94 0.35 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.287 3.324 . . . . 0.0 111.594 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -155.52 -48.8 0.08 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.553 1.141 . . . . 0.0 111.133 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -76.08 -28.32 57.54 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.849 1.26 . . . . 0.0 112.674 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.2 mt -122.54 165.28 16.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.898 1.679 . . . . 0.0 112.413 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -130.24 31.94 4.56 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.4 1.48 . . . . 0.0 113.219 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.81 34.22 89.34 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.949 -1.094 . . . . 0.0 113.99 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -58.03 152.98 36.79 Favored Pre-proline 0 C--O 1.242 0.669 0 C-N-CA 126.335 1.854 . . . . 0.0 112.855 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 N--CA 1.459 -0.536 0 C-N-CA 123.202 2.601 . . . . 0.0 111.12 179.619 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.475 0.788 0 CA-C-O 121.999 0.904 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 mt -95.82 133.65 25.15 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.263 1.825 . . . . 0.0 109.876 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.33 165.96 28.71 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 124.211 3.274 . . . . 0.0 112.542 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.28 65.3 5.37 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.722 3.614 . . . . 0.0 113.423 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.43 19.27 3.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.188 1.795 . . . . 0.0 113.005 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -111.88 -23.21 10.69 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.614 1.166 . . . . 0.0 113.903 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.28 118.63 6.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.593 1.157 . . . . 0.0 111.512 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -105.23 34.95 3.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.836 1.254 . . . . 0.0 112.0 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.29 15.6 64.11 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.233 0.921 . . . . 0.0 114.557 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -87.47 158.01 52.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.213 -1.169 . . . . 0.0 112.416 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 C--N 1.348 0.514 0 C-N-CA 123.596 2.864 . . . . 0.0 112.182 178.173 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.9 mt -133.07 128.16 20.43 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.611 1.164 . . . . 0.0 109.273 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.6 165.88 30.47 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.111 3.207 . . . . 0.0 113.528 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.7 79.05 0.5 Allowed 'Trans proline' 0 CA--C 1.545 1.07 1 C-N-CA 125.607 4.205 . . . . 0.0 113.491 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -145.31 -49.99 0.24 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.157 1.383 . . . . 0.0 112.066 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -81.71 -35.45 29.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.236 1.015 . . . . 0.0 112.647 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.25 141.78 52.41 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.728 0.811 . . . . 0.0 110.052 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -109.57 12.2 24.47 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.3 1.04 . . . . 0.0 113.44 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.26 11.82 68.16 Favored Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.996 -1.065 . . . . 0.0 114.7 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -74.39 153.85 87.95 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.23 1.812 . . . . 0.0 112.295 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 CA--C 1.542 0.881 0 C-N-CA 124.658 3.572 . . . . 0.0 112.368 179.369 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.22 129.79 74.14 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 120.772 -1.205 . . . . 0.0 109.977 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -72.51 167.29 27.43 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.331 3.354 . . . . 0.0 112.737 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.1 76.27 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.321 3.348 . . . . 0.0 112.339 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -143.46 -41.98 0.29 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.921 2.088 . . . . 0.0 112.536 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -73.62 -29.74 62.55 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.0 mt -66.94 167.31 11.9 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.722 2.009 . . . . 0.0 112.27 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -115.64 35.11 4.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.831 1.652 . . . . 0.0 111.262 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.25 -1.78 79.41 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.975 1.274 . . . . 0.0 115.848 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -68.35 161.25 70.9 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 118.925 1.363 . . . . 0.0 111.379 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 CA--C 1.539 0.765 0 C-N-CA 123.186 2.59 . . . . 0.0 113.077 176.463 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.675 0.75 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.8 mt -90.77 128.03 49.86 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.494 1.518 . . . . 0.0 109.127 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.51 164.59 34.74 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.189 3.259 . . . . 0.0 112.361 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.0 95.38 0.36 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.138 3.225 . . . . 0.0 112.392 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -162.7 -41.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.832 1.253 . . . . 0.0 112.854 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -84.82 -18.2 35.7 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.605 1.562 . . . . 0.0 112.844 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.2 mt -125.93 -179.94 4.92 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.973 2.509 . . . . 0.0 110.527 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -136.45 53.13 1.93 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.786 1.279 . . . . 0.0 112.233 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.62 43.84 93.73 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.23 0.919 . . . . 0.0 112.846 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 153.42 57.7 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 118.008 0.904 . . . . 0.0 112.452 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 C--N 1.35 0.651 0 C-N-CA 123.064 2.509 . . . . 0.0 110.96 -178.49 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 120.945 0.402 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mt -74.92 129.13 83.9 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -64.63 167.33 15.51 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.694 2.93 . . . . 0.0 111.825 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.07 64.25 2.58 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 123.821 3.014 . . . . 0.0 112.628 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.07 -51.69 1.03 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.074 1.349 . . . . 0.0 111.598 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -57.1 -24.43 53.99 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -104.84 106.4 16.88 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.788 2.035 . . . . 0.0 108.895 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -89.37 8.88 28.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.753 1.221 . . . . 0.0 112.614 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.67 30.02 75.53 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.912 -1.117 . . . . 0.0 113.238 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -118.05 154.71 51.62 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 126.288 1.835 . . . . 0.0 110.315 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.348 0.547 0 C-N-CA 122.914 2.409 . . . . 0.0 111.116 177.201 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.544 0.721 0 CA-C-O 122.328 1.061 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.1 mt -112.88 131.54 22.72 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.639 1.576 . . . . 0.0 108.908 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.23 164.35 35.32 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.191 2.594 . . . . 0.0 112.606 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.18 73.64 1.55 Allowed 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.472 3.448 . . . . 0.0 113.208 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -136.78 -52.49 0.7 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.369 1.868 . . . . 0.0 112.316 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -58.53 -28.74 65.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.5 mt -154.64 164.75 38.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.087 2.555 . . . . 0.0 108.933 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.36 30.04 7.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.459 1.504 . . . . 0.0 112.797 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.45 26.07 74.71 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.598 -1.314 . . . . 0.0 113.639 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -55.44 150.52 23.57 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.839 1.255 . . . . 0.0 112.071 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.35 0.615 0 C-N-CA 122.941 2.428 . . . . 0.0 110.059 176.541 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.73 131.42 39.74 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.499 1.519 . . . . 0.0 109.244 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.23 172.25 9.1 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.018 3.145 . . . . 0.0 112.792 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.52 63.67 2.24 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 124.436 3.424 . . . . 0.0 113.533 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -128.29 14.68 6.68 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.315 1.446 . . . . 0.0 114.333 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -122.66 9.64 9.59 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.548 1.539 . . . . 0.0 112.707 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.55 171.82 7.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.477 1.911 . . . . 0.0 111.626 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -130.46 13.97 5.5 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.114 1.365 . . . . 0.0 112.662 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.79 -45.94 1.25 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.556 2.027 . . . . 0.0 112.369 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -76.65 162.32 71.02 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.821 1.648 . . . . 0.0 112.343 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 CA--C 1.542 0.884 0 C-N-CA 123.64 2.893 . . . . 0.0 112.858 173.909 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.444 0.64 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.19 130.33 74.48 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.488 1.515 . . . . 0.0 109.425 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.74 162.75 33.25 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.938 2.425 . . . . 0.0 111.625 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.52 73.62 0.87 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.015 3.143 . . . . 0.0 112.538 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -141.36 9.3 2.05 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.153 2.181 . . . . 0.0 112.835 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -103.23 -32.78 9.44 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.1 1.36 . . . . 0.0 113.977 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 pp -80.75 153.18 27.94 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.745 1.218 . . . . 0.0 110.959 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -125.75 15.35 8.08 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.504 1.121 . . . . 0.0 113.304 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.56 -4.5 9.36 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.713 1.149 . . . . 0.0 114.652 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -123.99 159.7 55.3 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 127.377 2.271 . . . . 0.0 110.826 -174.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 CA--C 1.541 0.846 0 C-N-CA 122.505 2.137 . . . . 0.0 112.915 171.962 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.7 mm 56.25 67.05 3.01 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 125.382 1.473 . . . . 0.0 112.133 -173.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.76 160.13 48.04 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.876 3.051 . . . . 0.0 112.577 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.45 58.51 2.45 Favored 'Trans proline' 0 CA--C 1.547 1.159 1 C-N-CA 126.973 5.116 . . . . 0.0 115.106 -169.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -139.68 24.41 2.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.491 1.916 . . . . 0.0 111.874 -165.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -120.51 140.19 51.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.87 1.668 . . . . 0.0 110.198 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.43 -71.86 0.41 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.706 1.202 . . . . 0.0 110.513 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -173.61 164.19 4.42 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.27 2.228 . . . . 0.0 109.624 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.74 132.45 3.18 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.634 1.588 . . . . 0.0 110.477 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.7 tptp 30.72 69.27 0.69 Allowed Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.777 2.031 . . . . 0.0 113.662 -174.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 C-N-CA 123.628 2.885 . . . . 0.0 111.354 -173.309 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.94 140.69 55.21 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.866 0.866 . . . . 0.0 111.4 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.52 132.32 46.09 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.883 0.873 . . . . 0.0 112.072 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.6 mt -93.1 131.79 32.27 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.183 0.993 . . . . 0.0 109.879 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -68.91 174.05 9.31 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.322 2.681 . . . . 0.0 113.785 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.8 m -111.22 75.98 0.95 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.428 1.491 . . . . 0.0 110.48 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 t -81.77 45.78 0.93 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.544 1.137 . . . . 0.0 112.368 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.2 mm -86.19 130.19 50.86 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.273 1.029 . . . . 0.0 109.587 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.45 164.22 35.07 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.29 2.66 . . . . 0.0 111.991 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.99 74.66 2.89 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.775 3.65 . . . . 0.0 112.961 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -139.48 -37.36 0.5 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.058 1.743 . . . . 0.0 113.174 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -84.59 -35.0 23.05 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.95 0.9 . . . . 0.0 110.874 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -96.34 176.36 6.09 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.565 1.946 . . . . 0.0 111.411 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -134.54 18.95 3.6 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.387 1.475 . . . . 0.0 112.435 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.37 73.18 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.628 -1.096 . . . . 0.0 113.782 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -53.9 146.97 25.69 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.659 1.184 . . . . 0.0 111.661 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.27 113.63 2.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.879 2.386 . . . . 0.0 112.267 -175.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -69.45 176.79 3.21 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.949 0.88 . . . . 0.0 112.243 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.46 122.31 18.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 O-C-N 120.702 -1.249 . . . . 0.0 110.662 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 . . . . . 0 C--O 1.304 3.937 0 C-N-CA 126.9 2.08 . . . . 0.0 110.488 177.632 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 119.742 -0.17 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -53.33 115.75 2.08 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.864 0.866 . . . . 0.0 112.509 167.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.23 142.11 22.06 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.132 1.373 . . . . 0.0 109.801 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.2 mt -75.34 134.95 73.03 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.439 1.096 . . . . 0.0 109.577 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.1 103.57 1.07 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.378 2.718 . . . . 0.0 111.493 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.6 m -137.4 119.9 15.97 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.994 1.718 . . . . 0.0 110.552 -173.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.8 p -70.4 39.84 0.05 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 128.951 2.9 . . . . 0.0 115.924 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.6 130.29 47.72 Favored Pre-proline 0 CA--C 1.555 1.173 0 O-C-N 120.655 -1.278 . . . . 0.0 111.288 -167.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.68 169.25 22.67 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.331 3.354 . . . . 0.0 113.51 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.91 80.66 0.27 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.581 3.52 . . . . 0.0 112.956 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -149.76 -47.11 0.13 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -80.08 -17.9 51.41 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.964 1.306 . . . . 0.0 113.222 176.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.57 -179.2 7.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.808 1.643 . . . . 0.0 111.192 174.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.44 21.87 4.75 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.766 1.226 . . . . 0.0 113.056 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.13 41.31 97.08 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 120.93 -1.106 . . . . 0.0 112.601 -174.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -56.51 155.97 12.79 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.241 1.417 . . . . 0.0 111.017 175.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.18 156.38 55.73 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.032 1.821 . . . . 0.0 111.805 172.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -75.42 152.12 38.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.289 0.635 . . . . 0.0 111.702 168.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.2 m -76.89 161.95 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.301 1.441 . . . . 0.0 113.096 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.467 1.507 . . . . 0.0 112.498 -176.73 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -142.23 71.2 1.34 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.456 1.502 . . . . 0.0 109.019 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.17 43.22 3.04 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.727 1.211 . . . . 0.0 111.161 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mm -46.95 127.82 8.8 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.727 1.611 . . . . 0.0 110.713 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.02 87.76 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.719 2.946 . . . . 0.0 111.778 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.43 138.13 34.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.767 0.827 . . . . 0.0 111.195 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p -110.64 77.84 1.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.778 1.631 . . . . 0.0 111.297 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.58 132.3 95.36 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.358 1.063 . . . . 0.0 110.503 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.2 169.62 20.22 Favored 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 124.331 3.354 . . . . 0.0 112.856 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.12 75.61 1.35 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.356 3.371 . . . . 0.0 113.865 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -137.19 -37.91 0.63 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.808 1.643 . . . . 0.0 113.285 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -94.73 -34.32 12.58 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.766 -1.209 . . . . 0.0 112.006 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mp -133.59 160.0 38.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.894 2.078 . . . . 0.0 111.115 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -118.45 65.05 0.76 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.874 1.67 . . . . 0.0 111.659 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.49 7.73 6.15 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.293 1.425 . . . . 0.0 116.113 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -67.58 156.77 88.0 Favored Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 127.069 2.148 . . . . 0.0 112.636 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.03 138.03 42.73 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.854 2.369 . . . . 0.0 111.344 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -86.12 130.01 34.66 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.784 0.834 . . . . 0.0 110.379 172.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.8 m -84.86 161.51 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.373 1.469 . . . . 0.0 111.99 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.7 t80 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.01 0.924 . . . . 0.0 111.24 -178.688 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.5 mt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.65 0.262 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -58.82 135.27 57.45 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.423 1.489 . . . . 0.0 113.003 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.88 136.9 42.73 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.667 1.187 . . . . 0.0 111.07 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.6 mt -78.26 135.86 61.47 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.35 119.84 6.67 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.112 1.875 . . . . 0.0 110.063 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -125.86 156.53 39.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.409 1.483 . . . . 0.0 110.665 176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.9 t -118.87 31.59 6.57 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.485 1.114 . . . . 0.0 111.884 -169.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.8 mt -78.9 135.47 59.09 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.887 1.275 . . . . 0.0 109.891 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.98 166.73 26.89 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.676 2.917 . . . . 0.0 112.536 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.83 84.9 0.65 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.674 3.582 . . . . 0.0 112.401 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -149.85 -55.66 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.751 0.82 . . . . 0.0 111.78 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -71.66 -24.9 61.93 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.006 1.322 . . . . 0.0 112.687 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -112.67 151.93 29.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.616 1.966 . . . . 0.0 110.637 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -141.95 16.67 2.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.566 1.546 . . . . 0.0 113.503 -174.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.01 -26.66 3.1 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.51 1.529 . . . . 0.0 113.357 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -56.66 150.99 33.13 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.67 1.188 . . . . 0.0 112.155 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.83 174.04 11.78 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.389 2.726 . . . . 0.0 112.85 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -117.73 11.09 13.53 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.091 1.356 . . . . 0.0 112.955 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.84 83.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.823 1.649 . . . . 0.0 111.833 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.7 p90 . . . . . 0 C--O 1.254 1.335 0 C-N-CA 126.069 1.748 . . . . 0.0 112.876 -177.721 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 119.55 -0.262 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -136.24 111.79 9.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.735 2.014 . . . . 0.0 108.685 170.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.02 110.72 13.25 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.49 1.116 . . . . 0.0 110.784 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.78 128.47 81.62 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.798 0.839 . . . . 0.0 109.557 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -71.6 152.98 60.02 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.202 2.601 . . . . 0.0 112.566 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.0 m -67.98 110.15 3.78 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.745 0.818 . . . . 0.0 111.148 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -136.16 30.49 3.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.228 1.411 . . . . 0.0 112.054 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.5 mm -78.06 133.35 65.23 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.641 1.176 . . . . 0.0 108.544 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.5 160.26 50.01 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.714 2.276 . . . . 0.0 111.483 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.65 90.94 0.35 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.287 3.324 . . . . 0.0 111.594 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -155.52 -48.8 0.08 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.553 1.141 . . . . 0.0 111.133 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -76.08 -28.32 57.54 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.849 1.26 . . . . 0.0 112.674 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.2 mt -122.54 165.28 16.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.898 1.679 . . . . 0.0 112.413 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -130.24 31.94 4.56 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.4 1.48 . . . . 0.0 113.219 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.81 34.22 89.34 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.949 -1.094 . . . . 0.0 113.99 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -58.03 152.98 36.79 Favored Pre-proline 0 C--O 1.242 0.669 0 C-N-CA 126.335 1.854 . . . . 0.0 112.855 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.72 135.27 37.95 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.202 2.601 . . . . 0.0 111.12 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.73 104.57 0.69 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.968 0.907 . . . . 0.0 111.004 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.5 m -59.41 138.44 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.565 0.746 . . . . 0.0 110.053 170.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--O 1.264 1.845 0 CA-C-O 117.121 -1.419 . . . . 0.0 110.655 177.514 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -89.02 128.49 35.72 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.189 -0.945 . . . . 0.0 111.288 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.43 152.76 29.39 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.322 1.049 . . . . 0.0 111.377 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.9 mt -73.97 134.67 77.72 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.946 0.898 . . . . 0.0 109.511 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.2 171.12 14.41 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.259 2.639 . . . . 0.0 113.068 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.4 m -67.06 126.18 28.34 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.254 -0.904 . . . . 0.0 111.24 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 t -133.87 25.15 3.98 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.71 1.604 . . . . 0.0 111.624 -173.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 mt -95.82 133.65 25.15 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.263 1.825 . . . . 0.0 109.876 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.33 165.96 28.71 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 124.211 3.274 . . . . 0.0 112.542 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.28 65.3 5.37 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.722 3.614 . . . . 0.0 113.423 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.43 19.27 3.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.188 1.795 . . . . 0.0 113.005 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -111.88 -23.21 10.69 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.614 1.166 . . . . 0.0 113.903 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.28 118.63 6.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.593 1.157 . . . . 0.0 111.512 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -105.23 34.95 3.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.836 1.254 . . . . 0.0 112.0 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.29 15.6 64.11 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.233 0.921 . . . . 0.0 114.557 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -87.47 158.01 52.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.213 -1.169 . . . . 0.0 112.416 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.6 165.34 29.69 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.596 2.864 . . . . 0.0 112.182 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -67.46 162.15 23.81 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.6 m -125.37 44.46 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.165 1.386 . . . . 0.0 111.681 -173.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 124.825 1.25 . . . . 0.0 112.071 178.1 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.4 0.143 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -74.12 65.16 1.11 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.487 1.515 . . . . 0.0 113.289 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.24 91.49 0.96 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.377 1.471 . . . . 0.0 111.882 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.9 mt -92.58 137.47 24.33 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.362 1.065 . . . . 0.0 108.911 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.39 162.11 43.43 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.304 2.669 . . . . 0.0 112.34 174.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.9 t -147.01 126.34 13.09 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.387 -0.821 . . . . 0.0 112.054 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 t -146.11 135.6 23.07 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.516 0.726 . . . . 0.0 112.206 172.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.9 mt -133.07 128.16 20.43 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.611 1.164 . . . . 0.0 109.273 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.6 165.88 30.47 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.111 3.207 . . . . 0.0 113.528 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.7 79.05 0.5 Allowed 'Trans proline' 0 CA--C 1.545 1.07 1 C-N-CA 125.607 4.205 . . . . 0.0 113.491 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -145.31 -49.99 0.24 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.157 1.383 . . . . 0.0 112.066 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -81.71 -35.45 29.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.236 1.015 . . . . 0.0 112.647 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.25 141.78 52.41 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.728 0.811 . . . . 0.0 110.052 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -109.57 12.2 24.47 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.3 1.04 . . . . 0.0 113.44 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.26 11.82 68.16 Favored Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.996 -1.065 . . . . 0.0 114.7 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -74.39 153.85 87.95 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.23 1.812 . . . . 0.0 112.295 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.21 89.08 0.81 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 124.658 3.572 . . . . 0.0 112.368 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 t80 58.32 21.0 7.79 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.753 1.621 . . . . 0.0 114.437 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.73 46.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 126.716 2.006 . . . . 0.0 112.874 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.8 p90 . . . . . 0 C--O 1.247 0.928 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 173.109 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -106.17 32.89 4.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.903 1.281 . . . . 0.0 111.8 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.62 85.9 1.19 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.286 1.434 . . . . 0.0 111.787 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.3 mm -76.27 134.41 70.56 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.898 0.879 . . . . 0.0 110.299 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.26 -173.24 0.74 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.013 3.142 . . . . 0.0 113.007 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.0 m -117.84 4.24 12.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.177 1.391 . . . . 0.0 113.013 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -80.09 29.86 0.27 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.537 1.935 . . . . 0.0 113.793 177.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.22 129.79 74.14 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 120.772 -1.205 . . . . 0.0 109.977 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -72.51 167.29 27.43 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.331 3.354 . . . . 0.0 112.737 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.1 76.27 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.321 3.348 . . . . 0.0 112.339 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -143.46 -41.98 0.29 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.921 2.088 . . . . 0.0 112.536 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -73.62 -29.74 62.55 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.0 mt -66.94 167.31 11.9 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.722 2.009 . . . . 0.0 112.27 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -115.64 35.11 4.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.831 1.652 . . . . 0.0 111.262 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.25 -1.78 79.41 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.975 1.274 . . . . 0.0 115.848 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -68.35 161.25 70.9 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 118.925 1.363 . . . . 0.0 111.379 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.55 160.97 47.74 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.186 2.59 . . . . 0.0 113.077 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -79.95 90.42 5.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.908 1.283 . . . . 0.0 110.36 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.69 159.05 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.267 0.627 . . . . 0.0 112.419 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.3 t80 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 124.551 1.14 . . . . 0.0 111.746 -173.824 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.47 80.5 1.68 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.32 1.048 . . . . 0.0 111.876 -175.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.89 134.29 56.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.575 1.55 . . . . 0.0 112.989 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.5 mt -67.92 128.11 93.35 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.952 0.901 . . . . 0.0 109.866 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.29 114.53 3.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.963 2.442 . . . . 0.0 110.684 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.4 m -140.0 157.1 46.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.116 1.766 . . . . 0.0 110.019 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -84.03 59.21 5.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.63 1.172 . . . . 0.0 111.403 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.8 mt -90.77 128.03 49.86 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.494 1.518 . . . . 0.0 109.127 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.51 164.59 34.74 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.189 3.259 . . . . 0.0 112.361 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.0 95.38 0.36 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.138 3.225 . . . . 0.0 112.392 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -162.7 -41.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.832 1.253 . . . . 0.0 112.854 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -84.82 -18.2 35.7 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.605 1.562 . . . . 0.0 112.844 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.2 mt -125.93 -179.94 4.92 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.973 2.509 . . . . 0.0 110.527 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -136.45 53.13 1.93 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.786 1.279 . . . . 0.0 112.233 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.62 43.84 93.73 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.23 0.919 . . . . 0.0 112.846 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 153.42 57.7 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 118.008 0.904 . . . . 0.0 112.452 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.36 100.39 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.064 2.509 . . . . 0.0 110.96 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -78.71 128.33 33.29 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.859 -0.525 . . . . 0.0 110.539 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.85 112.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.774 0.829 . . . . 0.0 110.687 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 124.364 1.066 . . . . 0.0 112.687 -176.58 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 76.4 mt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -134.88 27.18 3.6 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.962 1.705 . . . . 0.0 112.809 -176.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.72 46.75 0.69 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.218 2.207 . . . . 0.0 113.757 -176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.7 127.3 66.93 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.472 1.109 . . . . 0.0 110.677 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.07 141.24 47.46 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.022 2.481 . . . . 0.0 111.591 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.1 p -150.36 161.46 42.44 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.095 0.958 . . . . 0.0 112.214 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.3 m -143.7 62.05 1.37 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.553 1.141 . . . . 0.0 110.132 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mt -74.92 129.13 83.9 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -64.63 167.33 15.51 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.694 2.93 . . . . 0.0 111.825 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.07 64.25 2.58 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 123.821 3.014 . . . . 0.0 112.628 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.07 -51.69 1.03 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.074 1.349 . . . . 0.0 111.598 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -57.1 -24.43 53.99 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -104.84 106.4 16.88 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.788 2.035 . . . . 0.0 108.895 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -89.37 8.88 28.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.753 1.221 . . . . 0.0 112.614 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.67 30.02 75.53 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.912 -1.117 . . . . 0.0 113.238 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -118.05 154.71 51.62 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 126.288 1.835 . . . . 0.0 110.315 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.05 132.82 33.3 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.914 2.409 . . . . 0.0 111.116 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -141.36 163.29 33.33 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.765 2.026 . . . . 0.0 109.02 -173.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.32 142.01 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 O-C-N 121.143 -0.973 . . . . 0.0 112.473 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 127.521 2.329 . . . . 0.0 113.619 -175.625 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -117.2 3.25 12.65 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.645 1.178 . . . . 0.0 113.262 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.72 113.77 6.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.214 1.406 . . . . 0.0 111.54 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.63 134.22 92.61 Favored Pre-proline 0 N--CA 1.474 0.758 0 C-N-CA 124.521 1.129 . . . . 0.0 110.247 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.27 123.32 10.44 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.617 2.211 . . . . 0.0 111.059 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.8 t -129.4 6.28 5.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.399 1.079 . . . . 0.0 112.269 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -89.99 50.21 1.84 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.182 1.793 . . . . 0.0 110.931 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.1 mt -112.88 131.54 22.72 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.639 1.576 . . . . 0.0 108.908 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.23 164.35 35.32 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.191 2.594 . . . . 0.0 112.606 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.18 73.64 1.55 Allowed 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.472 3.448 . . . . 0.0 113.208 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -136.78 -52.49 0.7 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.369 1.868 . . . . 0.0 112.316 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -58.53 -28.74 65.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.5 mt -154.64 164.75 38.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.087 2.555 . . . . 0.0 108.933 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.36 30.04 7.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.459 1.504 . . . . 0.0 112.797 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.45 26.07 74.71 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.598 -1.314 . . . . 0.0 113.639 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -55.44 150.52 23.57 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.839 1.255 . . . . 0.0 112.071 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -61.76 128.97 26.01 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.941 2.428 . . . . 0.0 110.059 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -117.53 105.63 12.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.986 0.914 . . . . 0.0 110.058 -170.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.43 40.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.436 1.494 . . . . 0.0 112.859 -165.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.5 t80 . . . . . 0 C--O 1.255 1.366 0 C-N-CA 125.562 1.545 . . . . 0.0 111.57 -174.359 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 121.251 0.548 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.05 83.62 2.28 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.416 0.686 . . . . 0.0 111.344 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.75 135.48 49.8 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.839 0.855 . . . . 0.0 110.763 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 mm -77.13 126.86 84.74 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.255 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -67.68 172.46 10.47 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.462 2.774 . . . . 0.0 111.642 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.9 m -72.63 127.41 32.47 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.653 -0.655 . . . . 0.0 111.367 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.5 p -132.35 13.19 4.6 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.978 0.911 . . . . 0.0 112.976 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.73 131.42 39.74 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.499 1.519 . . . . 0.0 109.244 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.23 172.25 9.1 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.018 3.145 . . . . 0.0 112.792 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.52 63.67 2.24 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 124.436 3.424 . . . . 0.0 113.533 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -128.29 14.68 6.68 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.315 1.446 . . . . 0.0 114.333 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -122.66 9.64 9.59 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.548 1.539 . . . . 0.0 112.707 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.55 171.82 7.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.477 1.911 . . . . 0.0 111.626 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -130.46 13.97 5.5 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.114 1.365 . . . . 0.0 112.662 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.79 -45.94 1.25 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.556 2.027 . . . . 0.0 112.369 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -76.65 162.32 71.02 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.821 1.648 . . . . 0.0 112.343 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.73 179.63 3.03 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.64 2.893 . . . . 0.0 112.858 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -123.73 164.35 19.32 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.398 1.079 . . . . 0.0 111.518 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.5 t -129.78 130.19 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.777 1.231 . . . . 0.0 110.149 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 124.829 1.252 . . . . 0.0 111.046 178.127 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -84.28 47.06 1.28 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.832 1.253 . . . . 0.0 111.794 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.55 71.66 3.19 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.272 1.429 . . . . 0.0 112.154 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.3 mt -49.21 128.46 16.27 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.009 1.324 . . . . 0.0 111.555 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.95 143.75 61.67 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.76 2.307 . . . . 0.0 111.703 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.3 p -148.68 160.84 42.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.843 1.257 . . . . 0.0 110.529 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.72 24.48 1.87 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.702 1.201 . . . . 0.0 112.508 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.19 130.33 74.48 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.488 1.515 . . . . 0.0 109.425 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.74 162.75 33.25 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.938 2.425 . . . . 0.0 111.625 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.52 73.62 0.87 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.015 3.143 . . . . 0.0 112.538 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -141.36 9.3 2.05 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.153 2.181 . . . . 0.0 112.835 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -103.23 -32.78 9.44 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.1 1.36 . . . . 0.0 113.977 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 pp -80.75 153.18 27.94 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.745 1.218 . . . . 0.0 110.959 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -125.75 15.35 8.08 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.504 1.121 . . . . 0.0 113.304 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.56 -4.5 9.36 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.713 1.149 . . . . 0.0 114.652 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -123.99 159.7 55.3 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 127.377 2.271 . . . . 0.0 110.826 -174.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.88 160.39 47.12 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.505 2.137 . . . . 0.0 112.915 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -62.84 149.3 44.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.621 1.168 . . . . 0.0 111.806 171.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.8 t -87.83 120.06 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.698 0.799 . . . . 0.0 111.156 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 C--O 1.249 1.056 0 C-N-CA 125.504 1.522 . . . . 0.0 112.624 178.118 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -77.55 58.24 1.72 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.441 1.497 . . . . 0.0 112.852 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.14 130.42 19.76 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.413 1.085 . . . . 0.0 111.54 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.0 152.56 62.18 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 126.171 1.788 . . . . 0.0 110.11 -174.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.13 -32.56 20.95 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.455 2.103 . . . . 0.0 112.32 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 30.5 p -76.92 169.08 18.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.641 1.576 . . . . 0.0 114.052 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 t -102.3 41.15 1.25 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.929 1.292 . . . . 0.0 112.888 -173.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.7 mm 56.25 67.05 3.01 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 125.382 1.473 . . . . 0.0 112.133 -173.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.76 160.13 48.04 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.876 3.051 . . . . 0.0 112.577 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.45 58.51 2.45 Favored 'Trans proline' 0 CA--C 1.547 1.159 1 C-N-CA 126.973 5.116 . . . . 0.0 115.106 -169.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -139.68 24.41 2.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.491 1.916 . . . . 0.0 111.874 -165.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -120.51 140.19 51.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.87 1.668 . . . . 0.0 110.198 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.43 -71.86 0.41 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.706 1.202 . . . . 0.0 110.513 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -173.61 164.19 4.42 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.27 2.228 . . . . 0.0 109.624 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.74 132.45 3.18 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.634 1.588 . . . . 0.0 110.477 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.7 tptp 30.72 69.27 0.69 Allowed Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.777 2.031 . . . . 0.0 113.662 -174.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.72 89.57 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.628 2.885 . . . . 0.0 111.354 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -120.17 23.9 10.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.884 1.674 . . . . 0.0 112.118 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.88 -178.49 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 128.061 2.544 . . . . 0.0 109.129 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.6 p90 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.478 1.911 . . . . 0.0 115.655 179.227 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 121.498 0.666 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.2 mm -86.19 130.19 50.86 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.273 1.029 . . . . 0.0 109.587 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.45 164.22 35.07 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.29 2.66 . . . . 0.0 111.991 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.99 74.66 2.89 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.775 3.65 . . . . 0.0 112.961 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -139.48 -37.36 0.5 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.058 1.743 . . . . 0.0 113.174 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -84.59 -35.0 23.05 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.95 0.9 . . . . 0.0 110.874 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -96.34 176.36 6.09 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.565 1.946 . . . . 0.0 111.411 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -134.54 18.95 3.6 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.387 1.475 . . . . 0.0 112.435 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.37 73.18 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.628 -1.096 . . . . 0.0 113.782 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -53.9 146.97 25.69 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.659 1.184 . . . . 0.0 111.661 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--N 1.348 0.527 0 C-N-CA 122.879 2.386 . . . . 0.0 112.267 -175.017 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.8 p . . . . . 0 CA--C 1.549 0.909 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.6 130.29 47.72 Favored Pre-proline 0 CA--C 1.555 1.173 0 O-C-N 120.655 -1.278 . . . . 0.0 111.288 -167.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.68 169.25 22.67 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.331 3.354 . . . . 0.0 113.51 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.91 80.66 0.27 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.581 3.52 . . . . 0.0 112.956 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -149.76 -47.11 0.13 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -80.08 -17.9 51.41 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.964 1.306 . . . . 0.0 113.222 176.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.57 -179.2 7.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.808 1.643 . . . . 0.0 111.192 174.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.44 21.87 4.75 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.766 1.226 . . . . 0.0 113.056 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.13 41.31 97.08 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 120.93 -1.106 . . . . 0.0 112.601 -174.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -56.51 155.97 12.79 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.241 1.417 . . . . 0.0 111.017 175.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 CA--C 1.539 0.771 0 C-N-CA 122.032 1.821 . . . . 0.0 111.805 172.27 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 122.364 1.078 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.58 132.3 95.36 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.358 1.063 . . . . 0.0 110.503 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.2 169.62 20.22 Favored 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 124.331 3.354 . . . . 0.0 112.856 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.12 75.61 1.35 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.356 3.371 . . . . 0.0 113.865 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -137.19 -37.91 0.63 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.808 1.643 . . . . 0.0 113.285 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -94.73 -34.32 12.58 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.766 -1.209 . . . . 0.0 112.006 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mp -133.59 160.0 38.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.894 2.078 . . . . 0.0 111.115 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -118.45 65.05 0.76 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.874 1.67 . . . . 0.0 111.659 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.49 7.73 6.15 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.293 1.425 . . . . 0.0 116.113 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -67.58 156.77 88.0 Favored Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 127.069 2.148 . . . . 0.0 112.636 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.458 -0.597 0 C-N-CA 122.854 2.369 . . . . 0.0 111.344 176.117 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 122.305 1.05 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.8 mt -78.9 135.47 59.09 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.887 1.275 . . . . 0.0 109.891 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.98 166.73 26.89 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.676 2.917 . . . . 0.0 112.536 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.83 84.9 0.65 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.674 3.582 . . . . 0.0 112.401 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -149.85 -55.66 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.751 0.82 . . . . 0.0 111.78 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -71.66 -24.9 61.93 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.006 1.322 . . . . 0.0 112.687 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -112.67 151.93 29.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.616 1.966 . . . . 0.0 110.637 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -141.95 16.67 2.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.566 1.546 . . . . 0.0 113.503 -174.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.01 -26.66 3.1 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.51 1.529 . . . . 0.0 113.357 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -56.66 150.99 33.13 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.67 1.188 . . . . 0.0 112.155 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo . . . . . 0 CA--C 1.538 0.724 0 C-N-CA 123.389 2.726 . . . . 0.0 112.85 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 122.338 1.066 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.5 mm -78.06 133.35 65.23 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.641 1.176 . . . . 0.0 108.544 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.5 160.26 50.01 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.714 2.276 . . . . 0.0 111.483 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.65 90.94 0.35 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.287 3.324 . . . . 0.0 111.594 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -155.52 -48.8 0.08 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.553 1.141 . . . . 0.0 111.133 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -76.08 -28.32 57.54 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.849 1.26 . . . . 0.0 112.674 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.2 mt -122.54 165.28 16.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.898 1.679 . . . . 0.0 112.413 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -130.24 31.94 4.56 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.4 1.48 . . . . 0.0 113.219 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.81 34.22 89.34 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.949 -1.094 . . . . 0.0 113.99 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -58.03 152.98 36.79 Favored Pre-proline 0 C--O 1.242 0.669 0 C-N-CA 126.335 1.854 . . . . 0.0 112.855 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 N--CA 1.459 -0.536 0 C-N-CA 123.202 2.601 . . . . 0.0 111.12 179.619 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.475 0.788 0 CA-C-O 121.999 0.904 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 mt -95.82 133.65 25.15 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.263 1.825 . . . . 0.0 109.876 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.33 165.96 28.71 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 124.211 3.274 . . . . 0.0 112.542 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.28 65.3 5.37 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.722 3.614 . . . . 0.0 113.423 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.43 19.27 3.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.188 1.795 . . . . 0.0 113.005 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -111.88 -23.21 10.69 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.614 1.166 . . . . 0.0 113.903 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.28 118.63 6.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.593 1.157 . . . . 0.0 111.512 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -105.23 34.95 3.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.836 1.254 . . . . 0.0 112.0 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.29 15.6 64.11 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.233 0.921 . . . . 0.0 114.557 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -87.47 158.01 52.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.213 -1.169 . . . . 0.0 112.416 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 C--N 1.348 0.514 0 C-N-CA 123.596 2.864 . . . . 0.0 112.182 178.173 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.9 mt -133.07 128.16 20.43 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.611 1.164 . . . . 0.0 109.273 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.6 165.88 30.47 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.111 3.207 . . . . 0.0 113.528 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.7 79.05 0.5 Allowed 'Trans proline' 0 CA--C 1.545 1.07 1 C-N-CA 125.607 4.205 . . . . 0.0 113.491 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -145.31 -49.99 0.24 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.157 1.383 . . . . 0.0 112.066 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -81.71 -35.45 29.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.236 1.015 . . . . 0.0 112.647 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.25 141.78 52.41 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.728 0.811 . . . . 0.0 110.052 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -109.57 12.2 24.47 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.3 1.04 . . . . 0.0 113.44 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.26 11.82 68.16 Favored Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.996 -1.065 . . . . 0.0 114.7 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -74.39 153.85 87.95 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.23 1.812 . . . . 0.0 112.295 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 CA--C 1.542 0.881 0 C-N-CA 124.658 3.572 . . . . 0.0 112.368 179.369 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.22 129.79 74.14 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 120.772 -1.205 . . . . 0.0 109.977 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -72.51 167.29 27.43 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.331 3.354 . . . . 0.0 112.737 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.1 76.27 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.321 3.348 . . . . 0.0 112.339 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -143.46 -41.98 0.29 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.921 2.088 . . . . 0.0 112.536 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -73.62 -29.74 62.55 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.0 mt -66.94 167.31 11.9 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.722 2.009 . . . . 0.0 112.27 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -115.64 35.11 4.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.831 1.652 . . . . 0.0 111.262 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.25 -1.78 79.41 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.975 1.274 . . . . 0.0 115.848 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -68.35 161.25 70.9 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 118.925 1.363 . . . . 0.0 111.379 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 CA--C 1.539 0.765 0 C-N-CA 123.186 2.59 . . . . 0.0 113.077 176.463 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.675 0.75 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.8 mt -90.77 128.03 49.86 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.494 1.518 . . . . 0.0 109.127 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.51 164.59 34.74 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.189 3.259 . . . . 0.0 112.361 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.0 95.38 0.36 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.138 3.225 . . . . 0.0 112.392 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -162.7 -41.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.832 1.253 . . . . 0.0 112.854 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -84.82 -18.2 35.7 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.605 1.562 . . . . 0.0 112.844 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.2 mt -125.93 -179.94 4.92 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.973 2.509 . . . . 0.0 110.527 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -136.45 53.13 1.93 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.786 1.279 . . . . 0.0 112.233 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.62 43.84 93.73 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.23 0.919 . . . . 0.0 112.846 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 153.42 57.7 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 118.008 0.904 . . . . 0.0 112.452 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 C--N 1.35 0.651 0 C-N-CA 123.064 2.509 . . . . 0.0 110.96 -178.49 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 120.945 0.402 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mt -74.92 129.13 83.9 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -64.63 167.33 15.51 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.694 2.93 . . . . 0.0 111.825 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.07 64.25 2.58 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 123.821 3.014 . . . . 0.0 112.628 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.07 -51.69 1.03 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.074 1.349 . . . . 0.0 111.598 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -57.1 -24.43 53.99 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -104.84 106.4 16.88 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.788 2.035 . . . . 0.0 108.895 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -89.37 8.88 28.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.753 1.221 . . . . 0.0 112.614 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.67 30.02 75.53 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.912 -1.117 . . . . 0.0 113.238 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -118.05 154.71 51.62 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 126.288 1.835 . . . . 0.0 110.315 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.348 0.547 0 C-N-CA 122.914 2.409 . . . . 0.0 111.116 177.201 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.544 0.721 0 CA-C-O 122.328 1.061 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.1 mt -112.88 131.54 22.72 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.639 1.576 . . . . 0.0 108.908 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.23 164.35 35.32 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.191 2.594 . . . . 0.0 112.606 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.18 73.64 1.55 Allowed 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.472 3.448 . . . . 0.0 113.208 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -136.78 -52.49 0.7 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.369 1.868 . . . . 0.0 112.316 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -58.53 -28.74 65.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.5 mt -154.64 164.75 38.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.087 2.555 . . . . 0.0 108.933 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.36 30.04 7.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.459 1.504 . . . . 0.0 112.797 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.45 26.07 74.71 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.598 -1.314 . . . . 0.0 113.639 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -55.44 150.52 23.57 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.839 1.255 . . . . 0.0 112.071 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 C--N 1.35 0.615 0 C-N-CA 122.941 2.428 . . . . 0.0 110.059 176.541 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.73 131.42 39.74 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.499 1.519 . . . . 0.0 109.244 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.23 172.25 9.1 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.018 3.145 . . . . 0.0 112.792 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.52 63.67 2.24 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 124.436 3.424 . . . . 0.0 113.533 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -128.29 14.68 6.68 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.315 1.446 . . . . 0.0 114.333 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -122.66 9.64 9.59 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.548 1.539 . . . . 0.0 112.707 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.55 171.82 7.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.477 1.911 . . . . 0.0 111.626 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -130.46 13.97 5.5 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.114 1.365 . . . . 0.0 112.662 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.79 -45.94 1.25 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.556 2.027 . . . . 0.0 112.369 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -76.65 162.32 71.02 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.821 1.648 . . . . 0.0 112.343 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 CA--C 1.542 0.884 0 C-N-CA 123.64 2.893 . . . . 0.0 112.858 173.909 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.444 0.64 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.19 130.33 74.48 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.488 1.515 . . . . 0.0 109.425 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.74 162.75 33.25 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.938 2.425 . . . . 0.0 111.625 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.52 73.62 0.87 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.015 3.143 . . . . 0.0 112.538 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -141.36 9.3 2.05 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.153 2.181 . . . . 0.0 112.835 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -103.23 -32.78 9.44 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.1 1.36 . . . . 0.0 113.977 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 pp -80.75 153.18 27.94 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.745 1.218 . . . . 0.0 110.959 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -125.75 15.35 8.08 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.504 1.121 . . . . 0.0 113.304 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.56 -4.5 9.36 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.713 1.149 . . . . 0.0 114.652 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -123.99 159.7 55.3 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 127.377 2.271 . . . . 0.0 110.826 -174.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 CA--C 1.541 0.846 0 C-N-CA 122.505 2.137 . . . . 0.0 112.915 171.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.7 mm 56.25 67.05 3.01 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 125.382 1.473 . . . . 0.0 112.133 -173.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.76 160.13 48.04 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.876 3.051 . . . . 0.0 112.577 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.45 58.51 2.45 Favored 'Trans proline' 0 CA--C 1.547 1.159 1 C-N-CA 126.973 5.116 . . . . 0.0 115.106 -169.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -139.68 24.41 2.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.491 1.916 . . . . 0.0 111.874 -165.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -120.51 140.19 51.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.87 1.668 . . . . 0.0 110.198 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.43 -71.86 0.41 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.706 1.202 . . . . 0.0 110.513 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -173.61 164.19 4.42 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.27 2.228 . . . . 0.0 109.624 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.74 132.45 3.18 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.634 1.588 . . . . 0.0 110.477 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.7 tptp 30.72 69.27 0.69 Allowed Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.777 2.031 . . . . 0.0 113.662 -174.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 C-N-CA 123.628 2.885 . . . . 0.0 111.354 -173.309 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.94 140.69 55.21 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.866 0.866 . . . . 0.0 111.4 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.52 132.32 46.09 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.883 0.873 . . . . 0.0 112.072 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.6 mt -93.1 131.79 32.27 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.183 0.993 . . . . 0.0 109.879 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -68.91 174.05 9.31 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.322 2.681 . . . . 0.0 113.785 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.8 m -111.22 75.98 0.95 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.428 1.491 . . . . 0.0 110.48 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 t -81.77 45.78 0.93 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.544 1.137 . . . . 0.0 112.368 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.2 mm -86.19 130.19 50.86 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.273 1.029 . . . . 0.0 109.587 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.45 164.22 35.07 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.29 2.66 . . . . 0.0 111.991 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.99 74.66 2.89 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.775 3.65 . . . . 0.0 112.961 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -139.48 -37.36 0.5 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.058 1.743 . . . . 0.0 113.174 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -84.59 -35.0 23.05 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.95 0.9 . . . . 0.0 110.874 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -96.34 176.36 6.09 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.565 1.946 . . . . 0.0 111.411 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -134.54 18.95 3.6 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.387 1.475 . . . . 0.0 112.435 -175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.37 73.18 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.628 -1.096 . . . . 0.0 113.782 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -53.9 146.97 25.69 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.659 1.184 . . . . 0.0 111.661 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.27 113.63 2.73 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.879 2.386 . . . . 0.0 112.267 -175.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -69.45 176.79 3.21 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.949 0.88 . . . . 0.0 112.243 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.46 122.31 18.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 O-C-N 120.702 -1.249 . . . . 0.0 110.662 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 . . . . . 0 C--O 1.304 3.937 0 C-N-CA 126.9 2.08 . . . . 0.0 110.488 177.632 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 N--CA 1.466 0.362 0 CA-C-O 119.742 -0.17 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -53.33 115.75 2.08 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.864 0.866 . . . . 0.0 112.509 167.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.23 142.11 22.06 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.132 1.373 . . . . 0.0 109.801 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.2 mt -75.34 134.95 73.03 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.439 1.096 . . . . 0.0 109.577 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.1 103.57 1.07 Allowed 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.378 2.718 . . . . 0.0 111.493 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.6 m -137.4 119.9 15.97 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.994 1.718 . . . . 0.0 110.552 -173.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.8 p -70.4 39.84 0.05 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 128.951 2.9 . . . . 0.0 115.924 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.6 130.29 47.72 Favored Pre-proline 0 CA--C 1.555 1.173 0 O-C-N 120.655 -1.278 . . . . 0.0 111.288 -167.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.68 169.25 22.67 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.331 3.354 . . . . 0.0 113.51 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.91 80.66 0.27 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.581 3.52 . . . . 0.0 112.956 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -149.76 -47.11 0.13 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -80.08 -17.9 51.41 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.964 1.306 . . . . 0.0 113.222 176.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.57 -179.2 7.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.808 1.643 . . . . 0.0 111.192 174.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.44 21.87 4.75 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.766 1.226 . . . . 0.0 113.056 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.13 41.31 97.08 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 120.93 -1.106 . . . . 0.0 112.601 -174.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -56.51 155.97 12.79 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.241 1.417 . . . . 0.0 111.017 175.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.18 156.38 55.73 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.032 1.821 . . . . 0.0 111.805 172.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -75.42 152.12 38.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.289 0.635 . . . . 0.0 111.702 168.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.2 m -76.89 161.95 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.301 1.441 . . . . 0.0 113.096 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.467 1.507 . . . . 0.0 112.498 -176.73 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -142.23 71.2 1.34 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.456 1.502 . . . . 0.0 109.019 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.17 43.22 3.04 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.727 1.211 . . . . 0.0 111.161 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.1 mm -46.95 127.82 8.8 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.727 1.611 . . . . 0.0 110.713 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.02 87.76 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.719 2.946 . . . . 0.0 111.778 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.2 t -82.43 138.13 34.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.767 0.827 . . . . 0.0 111.195 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p -110.64 77.84 1.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.778 1.631 . . . . 0.0 111.297 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.58 132.3 95.36 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.358 1.063 . . . . 0.0 110.503 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.2 169.62 20.22 Favored 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 124.331 3.354 . . . . 0.0 112.856 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.12 75.61 1.35 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.356 3.371 . . . . 0.0 113.865 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -137.19 -37.91 0.63 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.808 1.643 . . . . 0.0 113.285 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -94.73 -34.32 12.58 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.766 -1.209 . . . . 0.0 112.006 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mp -133.59 160.0 38.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.894 2.078 . . . . 0.0 111.115 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -118.45 65.05 0.76 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.874 1.67 . . . . 0.0 111.659 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.49 7.73 6.15 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.293 1.425 . . . . 0.0 116.113 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -67.58 156.77 88.0 Favored Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 127.069 2.148 . . . . 0.0 112.636 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.03 138.03 42.73 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.854 2.369 . . . . 0.0 111.344 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -86.12 130.01 34.66 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.784 0.834 . . . . 0.0 110.379 172.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.8 m -84.86 161.51 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.373 1.469 . . . . 0.0 111.99 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.7 t80 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.01 0.924 . . . . 0.0 111.24 -178.688 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.5 mt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.65 0.262 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -58.82 135.27 57.45 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.423 1.489 . . . . 0.0 113.003 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.88 136.9 42.73 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.667 1.187 . . . . 0.0 111.07 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.6 mt -78.26 135.86 61.47 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.35 119.84 6.67 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.112 1.875 . . . . 0.0 110.063 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -125.86 156.53 39.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.409 1.483 . . . . 0.0 110.665 176.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.9 t -118.87 31.59 6.57 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.485 1.114 . . . . 0.0 111.884 -169.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.8 mt -78.9 135.47 59.09 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.887 1.275 . . . . 0.0 109.891 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.98 166.73 26.89 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.676 2.917 . . . . 0.0 112.536 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.83 84.9 0.65 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.674 3.582 . . . . 0.0 112.401 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -149.85 -55.66 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.751 0.82 . . . . 0.0 111.78 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -71.66 -24.9 61.93 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.006 1.322 . . . . 0.0 112.687 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -112.67 151.93 29.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.616 1.966 . . . . 0.0 110.637 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -141.95 16.67 2.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.566 1.546 . . . . 0.0 113.503 -174.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.01 -26.66 3.1 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.51 1.529 . . . . 0.0 113.357 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -56.66 150.99 33.13 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.67 1.188 . . . . 0.0 112.155 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.83 174.04 11.78 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.389 2.726 . . . . 0.0 112.85 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -117.73 11.09 13.53 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.091 1.356 . . . . 0.0 112.955 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.84 83.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.823 1.649 . . . . 0.0 111.833 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.7 p90 . . . . . 0 C--O 1.254 1.335 0 C-N-CA 126.069 1.748 . . . . 0.0 112.876 -177.721 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 119.55 -0.262 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -136.24 111.79 9.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.735 2.014 . . . . 0.0 108.685 170.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.02 110.72 13.25 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.49 1.116 . . . . 0.0 110.784 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.78 128.47 81.62 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.798 0.839 . . . . 0.0 109.557 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -71.6 152.98 60.02 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.202 2.601 . . . . 0.0 112.566 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.0 m -67.98 110.15 3.78 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.745 0.818 . . . . 0.0 111.148 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -136.16 30.49 3.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.228 1.411 . . . . 0.0 112.054 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.5 mm -78.06 133.35 65.23 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.641 1.176 . . . . 0.0 108.544 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.5 160.26 50.01 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.714 2.276 . . . . 0.0 111.483 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.65 90.94 0.35 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.287 3.324 . . . . 0.0 111.594 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -155.52 -48.8 0.08 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.553 1.141 . . . . 0.0 111.133 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -76.08 -28.32 57.54 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.849 1.26 . . . . 0.0 112.674 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.2 mt -122.54 165.28 16.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.898 1.679 . . . . 0.0 112.413 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -130.24 31.94 4.56 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.4 1.48 . . . . 0.0 113.219 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.81 34.22 89.34 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.949 -1.094 . . . . 0.0 113.99 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -58.03 152.98 36.79 Favored Pre-proline 0 C--O 1.242 0.669 0 C-N-CA 126.335 1.854 . . . . 0.0 112.855 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.72 135.27 37.95 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.202 2.601 . . . . 0.0 111.12 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.73 104.57 0.69 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.968 0.907 . . . . 0.0 111.004 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.5 m -59.41 138.44 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.565 0.746 . . . . 0.0 110.053 170.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--O 1.264 1.845 0 CA-C-O 117.121 -1.419 . . . . 0.0 110.655 177.514 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -89.02 128.49 35.72 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.189 -0.945 . . . . 0.0 111.288 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.43 152.76 29.39 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.322 1.049 . . . . 0.0 111.377 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.9 mt -73.97 134.67 77.72 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.946 0.898 . . . . 0.0 109.511 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.2 171.12 14.41 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.259 2.639 . . . . 0.0 113.068 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.4 m -67.06 126.18 28.34 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.254 -0.904 . . . . 0.0 111.24 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 t -133.87 25.15 3.98 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.71 1.604 . . . . 0.0 111.624 -173.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 mt -95.82 133.65 25.15 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.263 1.825 . . . . 0.0 109.876 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.33 165.96 28.71 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 124.211 3.274 . . . . 0.0 112.542 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.28 65.3 5.37 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.722 3.614 . . . . 0.0 113.423 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -135.43 19.27 3.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.188 1.795 . . . . 0.0 113.005 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -111.88 -23.21 10.69 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.614 1.166 . . . . 0.0 113.903 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.28 118.63 6.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.593 1.157 . . . . 0.0 111.512 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -105.23 34.95 3.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.836 1.254 . . . . 0.0 112.0 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.29 15.6 64.11 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.233 0.921 . . . . 0.0 114.557 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -87.47 158.01 52.16 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.213 -1.169 . . . . 0.0 112.416 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -68.6 165.34 29.69 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.596 2.864 . . . . 0.0 112.182 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -67.46 162.15 23.81 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.6 m -125.37 44.46 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.165 1.386 . . . . 0.0 111.681 -173.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 124.825 1.25 . . . . 0.0 112.071 178.1 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.4 0.143 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -74.12 65.16 1.11 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.487 1.515 . . . . 0.0 113.289 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.24 91.49 0.96 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.377 1.471 . . . . 0.0 111.882 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.9 mt -92.58 137.47 24.33 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.362 1.065 . . . . 0.0 108.911 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.39 162.11 43.43 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.304 2.669 . . . . 0.0 112.34 174.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.9 t -147.01 126.34 13.09 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.387 -0.821 . . . . 0.0 112.054 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 t -146.11 135.6 23.07 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.516 0.726 . . . . 0.0 112.206 172.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.9 mt -133.07 128.16 20.43 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.611 1.164 . . . . 0.0 109.273 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.6 165.88 30.47 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.111 3.207 . . . . 0.0 113.528 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.7 79.05 0.5 Allowed 'Trans proline' 0 CA--C 1.545 1.07 1 C-N-CA 125.607 4.205 . . . . 0.0 113.491 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -145.31 -49.99 0.24 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.157 1.383 . . . . 0.0 112.066 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -81.71 -35.45 29.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.236 1.015 . . . . 0.0 112.647 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.25 141.78 52.41 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.728 0.811 . . . . 0.0 110.052 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -109.57 12.2 24.47 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.3 1.04 . . . . 0.0 113.44 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.26 11.82 68.16 Favored Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.996 -1.065 . . . . 0.0 114.7 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -74.39 153.85 87.95 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.23 1.812 . . . . 0.0 112.295 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.21 89.08 0.81 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 124.658 3.572 . . . . 0.0 112.368 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 t80 58.32 21.0 7.79 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.753 1.621 . . . . 0.0 114.437 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.73 46.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 126.716 2.006 . . . . 0.0 112.874 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.8 p90 . . . . . 0 C--O 1.247 0.928 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 173.109 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -106.17 32.89 4.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.903 1.281 . . . . 0.0 111.8 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.62 85.9 1.19 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.286 1.434 . . . . 0.0 111.787 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.3 mm -76.27 134.41 70.56 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.898 0.879 . . . . 0.0 110.299 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.26 -173.24 0.74 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.013 3.142 . . . . 0.0 113.007 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.0 m -117.84 4.24 12.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.177 1.391 . . . . 0.0 113.013 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 t -80.09 29.86 0.27 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.537 1.935 . . . . 0.0 113.793 177.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.6 mt -78.22 129.79 74.14 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 120.772 -1.205 . . . . 0.0 109.977 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -72.51 167.29 27.43 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.331 3.354 . . . . 0.0 112.737 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.1 76.27 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.321 3.348 . . . . 0.0 112.339 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -143.46 -41.98 0.29 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.921 2.088 . . . . 0.0 112.536 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -73.62 -29.74 62.55 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.0 mt -66.94 167.31 11.9 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.722 2.009 . . . . 0.0 112.27 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -115.64 35.11 4.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.831 1.652 . . . . 0.0 111.262 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.25 -1.78 79.41 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.975 1.274 . . . . 0.0 115.848 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -68.35 161.25 70.9 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 118.925 1.363 . . . . 0.0 111.379 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.55 160.97 47.74 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.186 2.59 . . . . 0.0 113.077 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -79.95 90.42 5.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.908 1.283 . . . . 0.0 110.36 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -64.69 159.05 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.267 0.627 . . . . 0.0 112.419 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.3 t80 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 124.551 1.14 . . . . 0.0 111.746 -173.824 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.47 80.5 1.68 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.32 1.048 . . . . 0.0 111.876 -175.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.89 134.29 56.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.575 1.55 . . . . 0.0 112.989 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.5 mt -67.92 128.11 93.35 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.952 0.901 . . . . 0.0 109.866 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.29 114.53 3.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.963 2.442 . . . . 0.0 110.684 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.4 m -140.0 157.1 46.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.116 1.766 . . . . 0.0 110.019 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -84.03 59.21 5.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.63 1.172 . . . . 0.0 111.403 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.8 mt -90.77 128.03 49.86 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.494 1.518 . . . . 0.0 109.127 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.51 164.59 34.74 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 124.189 3.259 . . . . 0.0 112.361 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.0 95.38 0.36 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.138 3.225 . . . . 0.0 112.392 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -162.7 -41.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.832 1.253 . . . . 0.0 112.854 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -84.82 -18.2 35.7 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.605 1.562 . . . . 0.0 112.844 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 72.2 mt -125.93 -179.94 4.92 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.973 2.509 . . . . 0.0 110.527 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -136.45 53.13 1.93 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.786 1.279 . . . . 0.0 112.233 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.62 43.84 93.73 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.23 0.919 . . . . 0.0 112.846 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 153.42 57.7 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 118.008 0.904 . . . . 0.0 112.452 -177.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.36 100.39 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.064 2.509 . . . . 0.0 110.96 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -78.71 128.33 33.29 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.859 -0.525 . . . . 0.0 110.539 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.85 112.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.774 0.829 . . . . 0.0 110.687 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 124.364 1.066 . . . . 0.0 112.687 -176.58 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 76.4 mt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -134.88 27.18 3.6 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.962 1.705 . . . . 0.0 112.809 -176.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.72 46.75 0.69 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.218 2.207 . . . . 0.0 113.757 -176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.7 127.3 66.93 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.472 1.109 . . . . 0.0 110.677 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.07 141.24 47.46 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.022 2.481 . . . . 0.0 111.591 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.1 p -150.36 161.46 42.44 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.095 0.958 . . . . 0.0 112.214 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.3 m -143.7 62.05 1.37 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.553 1.141 . . . . 0.0 110.132 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.8 mt -74.92 129.13 83.9 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -64.63 167.33 15.51 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.694 2.93 . . . . 0.0 111.825 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.07 64.25 2.58 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 123.821 3.014 . . . . 0.0 112.628 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.07 -51.69 1.03 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.074 1.349 . . . . 0.0 111.598 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -57.1 -24.43 53.99 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -104.84 106.4 16.88 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.788 2.035 . . . . 0.0 108.895 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -89.37 8.88 28.4 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.753 1.221 . . . . 0.0 112.614 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.67 30.02 75.53 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.912 -1.117 . . . . 0.0 113.238 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -118.05 154.71 51.62 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 126.288 1.835 . . . . 0.0 110.315 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.05 132.82 33.3 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.914 2.409 . . . . 0.0 111.116 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -141.36 163.29 33.33 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.765 2.026 . . . . 0.0 109.02 -173.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.32 142.01 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 O-C-N 121.143 -0.973 . . . . 0.0 112.473 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 127.521 2.329 . . . . 0.0 113.619 -175.625 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -117.2 3.25 12.65 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.645 1.178 . . . . 0.0 113.262 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.72 113.77 6.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.214 1.406 . . . . 0.0 111.54 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.63 134.22 92.61 Favored Pre-proline 0 N--CA 1.474 0.758 0 C-N-CA 124.521 1.129 . . . . 0.0 110.247 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.27 123.32 10.44 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.617 2.211 . . . . 0.0 111.059 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.8 t -129.4 6.28 5.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.399 1.079 . . . . 0.0 112.269 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -89.99 50.21 1.84 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.182 1.793 . . . . 0.0 110.931 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.1 mt -112.88 131.54 22.72 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.639 1.576 . . . . 0.0 108.908 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.23 164.35 35.32 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.191 2.594 . . . . 0.0 112.606 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.18 73.64 1.55 Allowed 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.472 3.448 . . . . 0.0 113.208 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -136.78 -52.49 0.7 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.369 1.868 . . . . 0.0 112.316 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -58.53 -28.74 65.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.5 mt -154.64 164.75 38.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.087 2.555 . . . . 0.0 108.933 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -119.36 30.04 7.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.459 1.504 . . . . 0.0 112.797 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.45 26.07 74.71 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.598 -1.314 . . . . 0.0 113.639 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -55.44 150.52 23.57 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.839 1.255 . . . . 0.0 112.071 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -61.76 128.97 26.01 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.941 2.428 . . . . 0.0 110.059 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -117.53 105.63 12.28 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.986 0.914 . . . . 0.0 110.058 -170.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.43 40.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.436 1.494 . . . . 0.0 112.859 -165.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.5 t80 . . . . . 0 C--O 1.255 1.366 0 C-N-CA 125.562 1.545 . . . . 0.0 111.57 -174.359 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 121.251 0.548 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.05 83.62 2.28 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.416 0.686 . . . . 0.0 111.344 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.75 135.48 49.8 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.839 0.855 . . . . 0.0 110.763 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 mm -77.13 126.86 84.74 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.255 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -67.68 172.46 10.47 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.462 2.774 . . . . 0.0 111.642 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.9 m -72.63 127.41 32.47 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.653 -0.655 . . . . 0.0 111.367 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.5 p -132.35 13.19 4.6 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.978 0.911 . . . . 0.0 112.976 171.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.73 131.42 39.74 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.499 1.519 . . . . 0.0 109.244 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.23 172.25 9.1 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.018 3.145 . . . . 0.0 112.792 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.52 63.67 2.24 Favored 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 124.436 3.424 . . . . 0.0 113.533 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -128.29 14.68 6.68 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.315 1.446 . . . . 0.0 114.333 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -122.66 9.64 9.59 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.548 1.539 . . . . 0.0 112.707 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.55 171.82 7.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.477 1.911 . . . . 0.0 111.626 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -130.46 13.97 5.5 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.114 1.365 . . . . 0.0 112.662 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.79 -45.94 1.25 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.556 2.027 . . . . 0.0 112.369 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -76.65 162.32 71.02 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.821 1.648 . . . . 0.0 112.343 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.73 179.63 3.03 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.64 2.893 . . . . 0.0 112.858 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -123.73 164.35 19.32 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.398 1.079 . . . . 0.0 111.518 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.5 t -129.78 130.19 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.777 1.231 . . . . 0.0 110.149 -168.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 124.829 1.252 . . . . 0.0 111.046 178.127 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -84.28 47.06 1.28 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.832 1.253 . . . . 0.0 111.794 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.55 71.66 3.19 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.272 1.429 . . . . 0.0 112.154 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.3 mt -49.21 128.46 16.27 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.009 1.324 . . . . 0.0 111.555 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.95 143.75 61.67 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.76 2.307 . . . . 0.0 111.703 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.3 p -148.68 160.84 42.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.843 1.257 . . . . 0.0 110.529 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.72 24.48 1.87 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.702 1.201 . . . . 0.0 112.508 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.19 130.33 74.48 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.488 1.515 . . . . 0.0 109.425 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.74 162.75 33.25 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.938 2.425 . . . . 0.0 111.625 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.52 73.62 0.87 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.015 3.143 . . . . 0.0 112.538 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -141.36 9.3 2.05 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.153 2.181 . . . . 0.0 112.835 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -103.23 -32.78 9.44 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.1 1.36 . . . . 0.0 113.977 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 pp -80.75 153.18 27.94 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.745 1.218 . . . . 0.0 110.959 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -125.75 15.35 8.08 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.504 1.121 . . . . 0.0 113.304 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.56 -4.5 9.36 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.713 1.149 . . . . 0.0 114.652 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -123.99 159.7 55.3 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 127.377 2.271 . . . . 0.0 110.826 -174.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.88 160.39 47.12 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.505 2.137 . . . . 0.0 112.915 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -62.84 149.3 44.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.621 1.168 . . . . 0.0 111.806 171.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.8 t -87.83 120.06 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.698 0.799 . . . . 0.0 111.156 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 C--O 1.249 1.056 0 C-N-CA 125.504 1.522 . . . . 0.0 112.624 178.118 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -77.55 58.24 1.72 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.441 1.497 . . . . 0.0 112.852 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.14 130.42 19.76 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.413 1.085 . . . . 0.0 111.54 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.0 152.56 62.18 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 126.171 1.788 . . . . 0.0 110.11 -174.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.13 -32.56 20.95 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.455 2.103 . . . . 0.0 112.32 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 30.5 p -76.92 169.08 18.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.641 1.576 . . . . 0.0 114.052 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 t -102.3 41.15 1.25 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.929 1.292 . . . . 0.0 112.888 -173.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.7 mm 56.25 67.05 3.01 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 125.382 1.473 . . . . 0.0 112.133 -173.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.76 160.13 48.04 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.876 3.051 . . . . 0.0 112.577 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.45 58.51 2.45 Favored 'Trans proline' 0 CA--C 1.547 1.159 1 C-N-CA 126.973 5.116 . . . . 0.0 115.106 -169.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -139.68 24.41 2.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.491 1.916 . . . . 0.0 111.874 -165.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -120.51 140.19 51.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.87 1.668 . . . . 0.0 110.198 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.43 -71.86 0.41 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.706 1.202 . . . . 0.0 110.513 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -173.61 164.19 4.42 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.27 2.228 . . . . 0.0 109.624 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.74 132.45 3.18 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.634 1.588 . . . . 0.0 110.477 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.7 tptp 30.72 69.27 0.69 Allowed Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 126.777 2.031 . . . . 0.0 113.662 -174.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.72 89.57 0.52 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.628 2.885 . . . . 0.0 111.354 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -120.17 23.9 10.72 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.884 1.674 . . . . 0.0 112.118 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.88 -178.49 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 128.061 2.544 . . . . 0.0 109.129 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.6 p90 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.478 1.911 . . . . 0.0 115.655 179.227 . . . . . . . . 0 0 . 1 stop_ save_